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SIGNALING COMPLEXES FORMED BY LUTEINIZING HORMONE RECEPTOR TRANS- 
ACTIVATION 
 
Signal transduction by luteinizing hormone (LH) receptors depends on hormone 
activation of these receptors, a process important for mammalian reproduction.  The LH receptor, 
a member of the G protein-coupled receptor (GPCR) family, undergoes hormone-induced LH 
receptor dimerization and/or oligomerization and translocation into small membrane 
compartments where receptors are confined and exhibit slow lateral diffusion.  However, the 
organization of the signaling complex confined within these structures is not clear.  In this 
project, we used single particle tracking methods to evaluate the lateral motions of wild type 
receptor FLAG-LHR-YFP and mutant receptors defective in hormone binding (LHR-hCG, +cAMP) 
or defective in signal transduction (LHR+hCG,-cAMP) after exposure to human chorionic 
gonadotropin (hCG). These studies showed that, when wild type LH receptors and mutant 
receptors are coexpressed and treated with 100 nM hCG, there are decreases in receptor lateral 
diffusion, the number of receptor-occupied membrane microdomains and the size of receptor-
containing membrane microdomains.  These results suggest that wild type LH receptors are 
capable of both cis-activation of nearby wild type LH receptors and transactivation of 
LHR-hCG,+cAMP , a receptor that is not able to bind hCG.  We then investigated interactions 
between wild type LH receptors and mutant receptors using homo-transfer fluorescence 
resonance energy transfer (FRET) methods.  We showed that LH receptors associate with one 
another and that the extent of self-association increases in response to increasing hCG 
concentrations.  Using homo-transfer FRET methods, we showed that mutant LH receptors are 
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trans-activated by wild type receptors and undergo aggregation in response to 100 nM hCG 
despite being unable to bind hCG directly.  Finally, we evaluated cAMP levels in cis-activated 
and trans-activated LH receptors using ICUE3, an EPAC-based reporter molecule for cAMP.  
We determined that increases in intracellular cAMP occur in cells expressing wild type receptors 
and exposed to increasing concentrations of hCG.  Similarly, cells co-expressing mutant 
receptors exhibit increased cAMP when there is a 1:10 transfection ratio of LHR+hCG,-cAMP to 
LHR-hCG,+cAMP indicating that trans-activation is occurring.  Disruption of membrane 
microdomains by pre-treatment of cells with 10 nM methyl--cyclodextrin for an hour has a 
negative effect on cAMP levels which indicates the importance of cholesterol-containing 
microdomains in signal transduction by LH receptors.  Together these results demonstrate that 
trans-activated LH receptors can undergo receptor aggregation in response to hormone binding 
and can signal effectively despite the absence of a signal-transduction sequence in the mutant 
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CHAPTER 1:  BACKGROUND AND SIGNIFICANCE 
 
1.1:   Introduction  
 
            Human chorionic gonadotropin (hCG) is heterodimeric glycoprotein hormone acting on a 
G protein coupled receptor, the luteinizing hormone (LH) receptor, which is capable of binding 
either hCG and LH.  The LH receptor, a member of the glycoprotein hormone receptor family, 
plays an important role in both normal and abnormal reproductive physiology in males and 
females (1-3).  In males the LH receptor regulates the function and development of Leydig cells.  
In women LH receptors are important for ovulation, corpus luteum formation and progesterone 
secretion.   
The LH receptor has become a target for drug discovery because of natural mutations in 
LH receptor where the receptor either cannot bind hormone or cannot initiate signal transduction 
and because of the relationship between these mutant receptors and human diseases such as 
Leydig cell hyperplasia.  Much of this research has focused on the mechanism of activation of 
LH receptors which is still poorly understood.   
LH receptor activation is generally accomplished through cis-activation of these 
glycoprotein hormone receptors.  Cis-activation involves binding of cognate hormone to the 
receptor‘s exodomain followed by interactions between the receptor exodomain and the receptor 
transmembrane domains and extracellular loops (4,5).   Trans-activation is believed to occur 
through interactions between a ligand-occupied exodomain on one receptor and the signaling 
domain of an adjoining receptor.  It is assumed that the trans-activated receptor takes on an 
“active” conformation and signals similarly to a fully functional receptor that has bound and 
retained ligand or to a constitutively-active receptor that has never seen ligand but signals 
2 
continuously nonetheless.  Whether LH receptor cis-activation and trans-activation includes 
protracted receptor-receptor interactions is examined in this research.       
  
1.2: G protein-coupled receptors (GPCR) 
G protein-coupled receptors (GPCRs) are the largest protein receptor family and are 
involved in signal transduction across membranes.  Sensory perception uses members of the 
GPCR family. As examples, visual perception uses rhodopsin and sense of smell is accomplished 
using receptors of the olfactory epithelium which bind odorants.  GPCRs have seven 
transmembrane domains (7TM) and undergo conformational changes after ligand binding, a 
process that transfers the signal through the cell membrane.  Their name is based on their ability 
to activate G proteins to induce intracellular signaling (6).  These receptors may also be called  
7TM receptors based on their seven transmembrane helical segments, a name that is more 
accurate since GPCRs can interact with other signaling molecules that are not G proteins (7).   
All GPCRs have seven transmembrane-spanning segments connected by intracellular and 
extracellular loops.  The N-terminal of GPCRs has the amino terminus and the C-terminal has 
often contains serine or threonine residues (Figure 1.1).  In mammals, many physiological 
processes are regulated by GPCRs and this makes them a target for pharmaceutical drugs (8).  
GPCRs are coupled to G proteins via their third transmembrane domain and cytoplasmic loop 
between transmembrane domains 2 and 3 as well as via the cytoplasmic tail in some receptors 
(6).  The size of the GPCRs can vary and about 800 different human genes for this class of 
receptors have been demonstrated from the analysis of genome sequences (9).   
The GPCR superfamily is further divided to three main classes of receptors.  Class A is  
the largest class of GPCR and this class accounts for about 85%  of the GPCR genes.  Class A  
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GPCRs are also called rhodopsin-like receptors. All GPCRs have a common structure and 
mechanism for transducing signal, but they lack homology in their sequences.  The first crystal 
structure of GPCRs was for bovine rhodopsin (10).  In 2007, the structure of β2-adrenergic 
receptor was described (11). Both β2-adrenergic receptors and rhodopsin have similar 
orientations of their seven-transmembrane helices but with different conformations in the second 
extracellular loop.  The structures of activated GPCRs have been also determined.  This is the 
structure formed after the extracellular binding domain engages ligand and causes 
conformational changes in the cytoplasmic surface of the receptor (12).   
Class B GPCRs, characterized by a large extracellular domain for ligand binding, are best 
exemplified by the parathyroid hormone receptor. The Class C GPCRs are a small group of 
receptors with a ligand binding domain located at the N-terminus tail.  An example of a Class C 
GPCR is the heterodimeric GABAB receptor.  These GPCRs are activated by an external signal, 
a ligand, which leads to activation of a G protein.  
It is important to recognize that, although many GPCRs have similar structures in their 
seven transmembrane domains, the remainder of their structures can be very different.  GPCR 
N-terminal domains are different in size and may contain the binding site for ligand.  Their 
C-terminal domains may also vary in size. 
   
1.3: Structure of LH and hCG 
The glycoprotein hormone family includes human chorionic gonadotropin (hCG), 
luteinizing hormone (LH), follicle-stimulating hormone (FSH) and thyroid-stimulating hormone 
(TSH).  LH and hCG, like other members of the glycoprotein hormone family, have a common 
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α-chain and hormone-specific β-chains.  Their receptors are GPCRs with large extracellular 
domains that binds the glycoprotein ligands (13).   
            Both LH and hCG are heterodimers whose subunits are non-covalently associated (14). 
hCG is comprised of 237 amino acids with a β-subunit containing 145 residues, six disulfide 
bridges and two N-linked glycosylation sites (14).  Its α-subunit contains 92 residues, five 
disulfide bridges, two N-linked glycosylation sites and four O-linked glycosylation sites.  
Glycoprotein hormones such as LH and hCG are glycosylated in the natural state and these 
carbohydrates have important roles in hormone stability and receptor signaling (15).  Other than 
glycosylation patterns, LH and hCG have very similar amino acid sequences, structural 
properties, chemical composition and functions.  hCG exhibits higher affinity binding to 
receptors than does LH, probably a consequence of its additional glycosylated sites.    
            In 1994, the structure of hCG was obtained at 2.6 Å resolution.  This crystal structure, 
however, was missing the four N-linked and the four O-linked oligosaccharides and the 
β-subunit (16).  In 2012, Cole added back these missing structures and predicted the final 
structure of hCG (17).  The α and β subunits of hCG are associated to form a heterodimer which 
is essential for receptor binding.  hCG forms a heterodimer by wrapping the β-subunit around the 
α-subunit and this wrapping is linked via a disulfide bond between Cys26-Cys110 to form a 
“seat-belt region” which is important in the stability of the heterodimer (18).  There are two 
sugar residues on the each one of the α-subunits and one sugar residue on the β-subunit.  The 
carbohydrates of the α-subunit are attached to Asn52 on the double stranded loop and to Asn78 
almost at the end of the β-hairpins. 
 
1.4: LH receptors  
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            LH receptors are members of the GPCR family (6) and are characterized by a large 
N-terminal extracellular domain containing the binding site for hCG and LH  (19).  The 
extracellular domain contains leucine-rich repeats and a short hinge region located between the 
leucine-rich repeat region and the first transmembrane helix (19).  The hinge region is thought to 
act as a flexible region that allows the leucine-rich repeat domain to physically convey bound 
hCG or LH to the transmembrane domains (20).  The leucine rich repeats are arranged in a 
horseshoe shape with parallel β strands and loops providing important binding sites for hormone 
(21).   
The transmembrane domains of the LH receptor, TM1-TM7, span the plasma membrane 
seven times and are connected by three extracellular and three intracellular loops (Figure 1.1).  
The transmembrane domains of the receptor anchor the receptor in the membrane and transduce 
the signal initiated in the extracellular domain to G proteins (Figure 1.1).   The three intracellular 
loops, especially loop 3, are important for interactions between the LH receptor and G proteins.  
The LH receptor also has six potential sites for N-linked glycosylation, all of which are located 
on the extracellular domain.  
            The human LH receptor contains 699 amino acids encoded by a single gene.  The human 
and rat LH receptor genes are about 80 kb in size and have 11 exons and 10 introns, respectively 
(22,23).  The cloning of complementary DNA for the human LH receptor was reported after the 
exon structure was identified (24).  The mature LH receptor is 80 kDa with an additional 15 kDa 
contributed by multiple carbohydrate chains (25).  The first and second extracellular loops of the 
receptor contain  cysteine residues as do other receptors of the GPCR superfamily.  These 
cysteine residues in rhodopsin receptor stabilize the seven-transmembrane helical by forming 
disulfide bridges (25).  Cysteine residues Cys257 and Cys258 on  exon 9 are important for LH 
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receptor expression on the plasma membrane; mutations of these cysteines lead to intracellular 
retention of the receptor without affecting ligand binding (25).  Furthermore,  mutation of 
cysteine residues in exon 1 (Cys8,12,14,22) indicates that these residues are important for ligand 
binding to the receptor (1).  Natural mutations of the LH receptor can lead to hormone-
independent signaling which occurs in Ledyig cell hyperplasia (26).  Shenker et al. (21) 
identified the first intrinsically active mutation of LH receptors in a patient with precious 
puberty.  
  
1.5: Signal transduction by LH receptors 
LH receptors have the ability to activate multiple G protein-dependent signaling 
pathways (27).  Activated LH receptors interact with heterotrimeric G proteins which consist of 
three subunits (α, β and γ) leading to activation of adenylate cyclase (AC) and phospholipase C 
(PLC) (Figures 1.6 and 1.7).  The LH receptor, like other GPCR family members, interacts 
mainly with Gs and, to a lesser extent with Gq and Gi.  Like many GPCRs, receptor activation 
includes changes in the transmembrane domains and sometimes involves participation by the 
extracellular domains (28).  The intracellular domains contact G proteins by interacting with the 
C-terminal domain of the receptor.  More specifically, LH receptor coupling to G proteins is 
dependent on the C-terminus of the third loop and involves protein-protein interactions (29).  
Signal transduction by the receptor through the membrane is not well understood.  It is 
known that the receptor, in the absence of hormone, interacts with a G protein and that both are 
in an inactive state.  Once ligand binds, the conformation of the receptor changes, the G protein 
is activated and dissociates from the receptor (Figure 1.5).  The receptor now can activate 
another G protein or switch back to an inactive state.   
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A new mechanism for receptor activation of the glycoprotein hormone receptors, termed 
trans-activation, has been proposed as an alternative to the traditional mechanism known as cis-
activation. (30).  LH receptor-mediated signal transduction via cis-activation involves high 
affinity binding of either LH or hCG to the receptor's exodomain and interactions between the 
hormone-occupied exodomain and the receptor endodomain (Figure 1.2 (4)). The receptor 
endodomain, as modeled by Fanelli and colleagues (31), is capable of interacting with Gs. LH 
receptors (30) and structurally-related FSH receptors (32) can also be activated by receptor 
trans-activation which involves at least two receptors (Figure 1.4).  A functional LH receptor 
exodomain binds ligand and then interacts with an adjoining receptor that has not bound ligand.  
This leads to signal transduction by the second receptor’s functional endodomain including 
activation of G proteins and adenylate cyclase. LH receptor trans-activation can be shown (30) 
using cells co-transfected with a functional LH receptor exodomain coupled to either a non-
signaling LH receptor endodomain or to a protein or lipid membrane anchor  (33) and with a 
second LH receptor containing one of several mutations in their exodomain that prevent binding 
of hormone. These cells produce cyclic AMP (cAMP) in response to hCG, presumably via 
signaling through the competent LH receptor endodomain. The demonstration of both cis- and 
trans-activation of LH receptors suggests that amplification of ligand signal may occur through 
sequential cis-activation of one receptor and by trans-activation of closely associated LH 
receptors.  More recently, it has been shown that co-expressing mutant LH receptors deficient in 
binding or in signaling produces a hormone-induced signal in transgenic mice (34).   
            Signals by the LH receptor arise primarily through cAMP and protein kinase A (PKA).  
Following hormone binding, the LH receptor is activated, there is a conformational change in the 
transmembrane domain and binding of the intracellular domain with G proteins (Figure 1.5).  G 
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proteins contain three distinct subunits α, β, and γ and, before ligand binding, are inactive.  In the 
inactive state, the α subunit is bound to GDP while the β and γ subunits help to anchor the 
heterotrimer in the inner leaflet of the plasma membrane.  When receptor is activated, GDP is 
released from the α-subunit resulting in the activation of G protein and dissociation from both the 
activated receptor and the β and γ subunits  (19).  Activation LH receptor leads to the activation 
of the G protein Gs.  Following dissociation from β and γ, the α subunit activates adenylate 
cyclase.  Activation of adenylate cyclase, in turn, converts adenosine triphosphate (ATP) to the 
second messenger molecule cAMP (Figure 1.6).  cAMP binds to the regulating subunit of PKA 
and causes activation of its subunits.  Upon receptor activation, phospholipase C (PLC) 
hydrolyzes the membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2), yielding inositol 
1,4,5-triphosphate (IP3) and 1,2-diacylglycerol (DAG).  IP3 leads to release of sequestered 
intracellular Ca+2 ions from endoplasmic reticulum.  DAG increases the catalytic activity of 
protein kinase C (PKC) (Figure 1.7).                 
 
1.6: GPCR dimerization or oligomerization 
            For many years G protein-coupled receptors (GPCR) were thought to function as  
monomers but the concept that GPCRs can form dimers or oligomers has become widely 
accepted (35).  The evidence for signal transduction by dimerization of GPCR was first 
demonstrated for GABAB, metabotropic glutamate and calcium-sensing receptors (36).  
Oligomerization of GPCRs may be required for function as described for purified leukotriene B4 
receptor (37).  There is evidence of dimerization and oligomerization for some of GPCRs 
accompanying receptor activation.  GPCR  homodimers have been demonstrated for the 
β2-adrenergic receptor, the δ-opioid receptor, and the dopamine D1, D2 and D3  receptors (6).  
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GPCRs interact with components of the membrane bilayer such as lipids and with other GPCRs 
to form dimers or oligomers. These dimers and higher order-oligomers can affect ligand binding 
and signaling of GPCRs (38).   
 The serotonin1A receptor is a member of GPCR superfamily and serves as an important 
target for drugs.  The oligomerization state of serotonin1A receptors has been observed using a 
homo-FRET measurements where fluorescence anisotropy increases with fluorophore 
photobleaching (39).  In the glutamate receptor family of GPCRs, dimerization is important for 
receptor activation (40).  For rhodopsin family members, dimerization may play a role in the 
receptor activation.  However, the rhodopsin receptor could exist as a homodimers in the outer 
membrane as shown by microscopy images (41).  Oligomerization of LH receptors has also been 
observed (42-44).   
            A number of methods have been used to demonstrate dimerization or oligomerization of 
GPCRs.  A biochemical technique commonly used to identify the oligomerization state of GPCR 
is co-immunoprecipitation.  In the co-immunoprecipitation technique, cells which express two 
epitope-tagged receptors are solubilized and the lysate is incubated with an antibody against one 
of the epitope tags (7).  Then the complex is bound to a medium, electrophoresed, blotted and 
visualized using an antibody against the epitope tag on the second receptor of interest (7).  
Dimerization of GPCRs is induced by ligand binding to the receptor and this procedure is 
repeated.  Dimerization of β2-adrenergic receptor increases with the addition of its ligand 
isoproterenol (45).   Ligand-induced receptor dimerization has been also demonstrated for 
CXCR2, CCR5 and CCR2 receptors (35).  Dimers or oligomers of several GPCRs have been 
described during receptor desensitization or internalization either before, during, or after ligand 
binding (34).   
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1.7: The role of cholesterol in receptor function  
Cholesterol is an amphiphilic sterol with a small –OH head group and four rigid rings 
that interact with plasma membrane phospholipids through their hydrophobic tails (46).  
Cholesterol is an important component of the plasma membrane and can play an important role 
in the function of membrane proteins (47) including a number of GPCRs.   Cholesterol analogues 
and membrane fluidity measurements during receptor activity have been used to demonstrate 
direct and indirect cholesterol-receptor interactions (46).  Direct interactions between cholesterol 
and membrane proteins have been demonstrated for some GPCRs including serotonin1A 
receptors (48).  A specific binding site for cholesterol on the β2-adrenergic receptor has been 
described (49).   
There is evidence indicating that membrane cholesterol affects signal transduction by 
GPCRs.  Cholesterol is important for formation of lipid microdomains (lipid rafts) (50) which 
are enriched in cholesterol and sphingolipids and thought to act as a signaling platforms for 
GPCRs.  As an example, Smith et al. (51) have demonstrated that the LH receptors, upon 
hormone binding, become confined in small membrane microdomains which are essential for 
ligand-mediated receptor signaling.     
How cholesterol functionally regulates GPCRs and how cells control cholesterol 
distribution is not understood.  Nor is it clear whether these mechanisms are of pharmacological 
importance.  However, cholesterol depletion using methyl-β-cyclodextrin leads to a decrease in 
the oligomerization of the serotonin receptors and decreased signal transduction in response to 
ligand (39).  Decreasing cholesterol levels in membranes expressing µ-opioid receptors are 
accompanied by decreases in dimerization of the receptor and in receptor association with Gα, a 
result that reflects the importance of cholesterol in signaling transduction (52). 
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1.8: Single particle tracking  
            Single particle tracking (SPT) has become an important tool for studying the movement 
of molecules in live cells.  The aim of SPT is to understand motion of individual molecules or 
particles in specific environments and to describe their lateral dynamics quantitatively (53).  
Single particle tracking permits measurement of the individual trajectory of a molecule on the 
cell surface (54). The trajectories obtained from SPT experiments provide the molecule’s mean 
square displacement (MSD) which is  the average square distance that a particle moves in a time 
period (55).  The diffusion coefficient (D) can be calculated from the slope of a plot of MSD vs. 
time (56).  Daumas et al. have calculated the diffusion coefficient from the first two points of the 
MSD plot (57). 
 
1.9: Fluorescence resonance energy transfer (FRET) 
FRET is a biophysical technique that can evaluate interactions between membrane 
receptors.  FRET techniques include both hetero-transfer FRET and homo-transfer FRET.  In 
FRET the energy is transferred from an excited donor to an acceptor when the donor and 
acceptor are less than about 10 nm apart (58).  When a donor and acceptor fluorescent molecules 
are close, the emission spectrum of the donor overlaps the excitation spectrum of the acceptor, 
the donor emission is decreased and acceptor emission can be detected.  FRET techniques have 
been used by researchers to study a variety of biological processes including receptor-receptor 
interactions that occur as part of oligomerization of GPCRs.   
1.10: Hetero-FRET 
 Hetero-FRET is  FRET   between   two different  fluorescent proteins where one acts as a 
fluorescence donor and the other  is a fluorescence acceptor.   Commonly used FRET pairs 
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include CFP and YFP or CFP and GFP.  Cyan fluorescent protein (CFP) and yellow fluorescent 
protein (YFP) are color variants of green fluorescent protein (GFP).  Donor (CFP) excitation 
results in energy transfer to the acceptor (YFP) and emission by the acceptor when both donor 
and acceptor are at distances less than about 10 nm (58).   
 
1.11: Homo-FRET 
FRET usually refers to energy transfer between two different fluorophores, one acting as 
a donor and the other acting as an acceptor.  However, in some biological conditions, researchers 
need to evaluate interactions between two copies of a single protein (59).  In homo-transfer 
FRET both proteins will emit light with the same wavelengths but with differences in 
polarization between excitation and emission light of the fluorophores which can be detected 
(Figure 1.4).  Thus energy is transferred between two identical donor and acceptor molecules 
(58).  If the donor and acceptor molecules are sufficiently close for energy transfer, the emitted 
energy is polarized like the donor molecules, but less anisotropy is seen in FRET because the 
acceptor is oriented differently (Figure 1.8 (60)).  Decreased polarization reflects an increase in 
self-association and suggests that molecules of interest are in a dimeric or oligomeric structure. 
Anisotropy is measured by collecting images using polarizers to obtain images of 
fluorescence emitted parallel (I∥) and perpendicular (I⊥) to the polarization of the exciting light.  













   (1) 
 where I∥ and I⊥ are the intensities of the parallel and perpendicular polarized emission. Homo-
transfer FRET can be used to examine protein-protein interaction on individual cells and it is 
widely used to evaluate the aggregation state in living cells (61).   
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1.12: EPAC-Based FRET Sensors 
FRET-based sensors are ideal to measure the changes in intracellular concentrations of 
cAMP, a second messenger involved in GPCR signaling.  cAMP is an important intermediate 
that regulates various cellular functions through protein kinase A (PKA) and Epac, an exchange 
protein directly activated by cAMP (62).  Several Epac-based reporters called ICUE probes have 
been created using full length Epac1 or truncated forms of Epac2 sandwiched between ECFP and 
citrine. Similar to the biosensors formed from EPAC, ICUE3 was constructed by replacing 
citrine with a circularly permuted YFP.   In FRET-based sensing, binding of cAMP to Epac 
induces an unfolding of CFP and YFP domains which increases the distance between CFP and 
YFP and increases the ratio of CFP emission to YFP sensitized emission  (Figure 1.9 (63)). 
 
1.13: Hypothesis 
Cis-activation of the glycoprotein hormone receptors, including receptors for luteinizing 
hormone (LH), involves binding of cognate hormone to these receptors' large exodomains 
followed by interactions between the receptor exodomain and the receptor transmembrane 
domain and extracellular loops (4,5). Intracellular signaling arising from these interactions is 
essential for development, regulation of metabolism and reproductive function.  In addition to 
cis-activation, trans-activation of glycoprotein hormone receptors may amplify hormone signals.  
Trans-activation is believed to occur through interactions between a ligand-occupied exodomain 
on one receptor and the signaling domain of an adjoining receptor.  It is assumed that the trans-
activated receptors takes on an “active” conformation and signal similarly to a fully functional 
receptor that has bound and retained ligand or to a constitutively-active receptor that has never 
seen ligand but signals continuously nonetheless. We hypothesize that hormone activation of 
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LH receptors leads to formation of a signaling complex containing active receptors and 
that both cis- and trans-activated receptors are present in small membrane microdomains 









Figure 1.1: G protein-coupled hormone receptor. The luteinizing hormone (LH)/human 
chorionic gonadotropin (hCG) receptor is a representative of group II of the G protein-coupled 
receptors.  The LH/hCG receptor is composed of seven highly conserved transmembrane 
domains (I through VII), a large extracellular domain with six potential glycosylation sites and a 












Figure 1.2: A and B: Schematic presentation of intramolecular (cis) and intermolecular (trans) 
activation of GPCRs. In cis-activation (A), the hormone-occupied exo-domain is capable of 
intramolecular activation of its cognate endo-domain. In trans-activation (B), the hormone-
occupied exo-domain is capable of intramolecular activation of the endo-domain of the 

















Figure 1.3: Schematic representation of cis-activation on the left and trans-activation on the 
right of LH receptors leading to receptor clustering, raft localization and increased intracellular 





























































Figure 1.4: Polarization of fluorescence. (A) Fluorophore with randomly-oriented transition 
dipoles within an isotropic distribution.  (B) When the isotropic distribution of fluorophors is 
excited with vertically polarized light, fluorophores oriented in parallel to the vertical 
polarization of exciting light are excited. (C) The excited fluorophores transfer energy to 
























































Figure 1.8: FRET results in depolarization of the fluorescence signal.  The extent of such 

















Figure 1.9: ICUE3 consists of an Epac1 149−881 sensing unit flanked by an ECFP donor and a 
cpV-L194 acceptor reporting unit.  Upon binding cAMP, the sensor switches from a high FRET 










CHAPTER 2: MATERIALS AND METHODS  
 
2.1:   Introduction Single Particle Tracking (SPT)   
 Single particle tracking (SPT) is a biophysical technique that utilizes optical microscopy 
to provide important information about the diffusion of individual protein molecules on live cells 
(55).  SPT also offers multiple advantages for evaluating protein diffusion when compared with 
other light microscope techniques (67).   One of the important advantages of SPT is that it can 
give rates of diffusion for single molecules.  In contrast, a related method, fluorescence recovery 
after photobleaching, provides diffusion coefficients for all molecules in an illuminated region of  
the cell surface, typically at least 50 proteins.  Our lab previously examined the diffusion 
coefficient of LH receptors using colloidal gold particles and single particle tracking methods. In 
these earlier studies 40 nm gold particles were used as probes for labeling the LH receptors on 
the surface of living cells and the motion of these labeled receptors was imaged using light 
microscopy.  In the present study, we use quantum dots (QDs) to examine the diffusion 
coefficient of LH receptors.  QDs are inorganic semi-conducting nanoparticles that are 10-100 
times brighter than organic dyes.  QDs are attached to molecules of interest and imaged by light 
microscopy to obtain particle trajectories that are analyzed to obtain the mean square 
displacement of the particle and to distinguish between the different possible motions of the 
molecules. 
 
2.2: Materials and cell culture 
           CHO (Chinese hamster ovary) cells were purchased from American Type Culture 
Collection (Manassas, VA).  CHO cells were maintained in high glucose Dulbecco’s 
Modification of Eagle’s Medium (DMEM).  DMEM medium was purchased from Corning 
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Cellgro (Visalia, CA) supplemented with 10% fetal bovine serum (FBS).  FBS was purchased 
from Atlas Biologicals (Fort Collins, CO). Penicillin/streptomycin and L-glutamine solution 
were purchased from Gemini Bio-Products (West Sacramento, CA). 100x MEM non-essential 
amino acid solution and ethylenediamine tetraacetic acid (EDTA) were purchased from Sigma-
Aldrich, Inc. (St.Louis, MO).  Human chorionic gonadotropin (hCG) was purchased from 
Fitzgerald Industries (Acton, MA) and prepared in 1x PBS.  Monoclonal anti-FLAG biotin 
antibody was purchased from Sigma-Aldrich, Inc. (St. Louis, MO).  Qdot 605-streptavidin-
conjugated quantum dots were purchased from Invitrogen (Carlsbad, CA).  Lipofectamine 3000 
regent and OPTI-MEM reduced serum medium were purchased from Life Technology 
(Carlsbad, CA).  35 mm diameter glass-bottom cell culture dishes with 14 mm diameter glass 
bottoms were purchased from Invitro Scientific (Sunnyvale, CA).  CHO cells were grown in 5% 
CO2 at 37°C in a humidified environment.  
 
2.3: Amplification of FLAG-LHR-YFP in E. coli competent cells (DH5α) 
            2-5 µg of DNA plasmid (FLAG-LHR-YFP) was added to 50 µL of competent cells 
(DH5α) max efficiency.  A mixture of E. coli (DH5α) with FLAG-LHR-YFP was heat shocked 
for 45 seconds at 42°C and then transferred to ice for 2 minutes.  950 µL LB liquid media was 
added to the mixture of E .coli cells with FLAG-LHR-YFP and were grown at 37°C with 
vigorous shaking at 225 rpm for one hour.  E. coli cells with FLAG-LHR-YFP were plated 
together on LB-agar with antibiotic and cells were grown overnight at 37°C.  A single colony 
was selected and incubated overnight with 3-5 mL of LB-broth media at 37°C with vigorous 
shaking at 250 rpm.  Plasmid DNA was purified using a Qiagen mini-prep kit. 
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2.4: Amplification of FLAG-LHR+hCG,-cAMP  and HA-LHR-hCG,+cAMP plasmids using E. coli cells 
(DH5α) 
            2-5 µg of DNA plasmid (FLAG-LHR+hCG,-cAMP or HA-LHR-hCG,+cAMP) was added to 50 µL of 
competent cells (DH5α) max efficiency.  A mixture of E. coli (DH5α) with FLAG-LHR+hCG,-cAMP 
or HA-LHR-hCG,+cAMP  were heat shocked for 45 seconds at 42°C and then transferred to ice for 2 
minutes.  950 µL LB liquid media was added to the mixture of E. coli cells with 
FLAG-LHR+hCG,-cAMP or HA-LHR-hCG,+cAMP  and cells were grown at 37°C with vigorous shaking at 
225 rpm for one hour.  E. coli cells with FLAG-LHR+hCG,-cAMP  or HA-LHR-hCG,+cAMP were plated on 
LB-agar with antibiotic and cells were grew overnight at 37°C.  A single colony was selected 
and incubated overnight with 3-5 mL of LB-broth media at 37°C with vigorous shaking at 250 
rpm.  Plasmid DNA was purified using a Qiagen mini-prep kit. 
 
2.5: Transfection of CHO cells with FLAG-LHR-YFP 
 CHO cells were grown in a 25 cm2 culture flask in DMEM medium supplemented with 2 
mM L-glutamine, 10% fetal bovine serum (FBS), 1% penicillin/streptomycin and 1% 1x MEM 
non-essential amino acid solution. Cells were grown in 5% CO2 at 37°C in a humidified 
environment. CHO cells were transiently transfected with FLAG-LHR-YFP, kindly prepared by 
Dr. Xiaorong Li (Southwest University, Chongqing, China), using Lipofectamine 3000 in 
accordance with the Manufacturer’s instructions. Two sterilized microcentrifuge tubes were 
needed, each one containing 125μL of OPTI-MEM medium.  Tube one contained 5μL LP300 
reagent and 0.4 μg of FLAG-LHR-YFP.  Tube two contained 7.5μL of Lipofectamine 3000.  
Tube one was added drop wise to tube two and the mixture was incubated at room temperature 
for 5 to 15 min.  The incubated mixture was added to the CHO cells.  Cells were plated in a 
35mm glass-bottom Petri dish and grown to approximately 80% confluence in 1mL OPTI-MEM 
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reduced serum medium.  Cells were maintained in a humidified incubator in 5% CO2 at 37°C.  
Transfection proceeded for at least 24 hours. 
CHO cells were transiently co-transfected with 0.4 µg HA-LHR-hCG,+cAMP and 
FLAG-LHR+hCG,-cAMP.  These vectors were kindly provided by Dr. Aylin Hanyaloglub and Dr. Jonas 
Kim, members of Dr. IIpo T. Huhtaniemi’s research group at Imperial University, UK.  
Co-transfection procedures were similar to those used to transfect CHO cells with 
FLAG-LHR-YFP above. 
 
 2.6: Labeling with anti-FLAG-biotin antibody and QD 605-streptavidin: 
CHO cells expressing either wild type FLAG-LHR-YFP or FLAG-LHR+hCG,-cAMP and 
HA-LHR-hCG,+cAMP were seeded onto sterile culture dishes and grown to 70% confluence.  All 
labeling was performed in Tyrodes buffer containing 0.1% BSA. Cells were labeled first with 
anti-FLAG-biotin antibody at 0.2µg/mL for 30 min,  washed three times for 1 min in 1 mL 
buffer, labeled with QD 605-streptavidin for 10 min and washed 6 times for 1 min in 1 mL of 
buffer.  The QDs were then imaged.  The binding specificity for FLAG-tagged receptors was 
tested by pre-incubating cells with excess of anti-FLAG antibody. 
 





 on individual CHO cells 
            We examined the diffusion coefficient and confinement of LH receptors in plasma 
membrane microdomains by tracking the movement of individual receptors using single particle 
tracking methods as described by Kusumi and colleagues  (68).  CHO cells expressing 
FLAG-LHR-YFP alone or co-expressing FLAG-LHR+hCG,-cAMP  with HA-LHR-hCG,+cAMP  were 
seeded onto 35 mm2 Petri dishes  and grown to 50% confluence.  All labeling was performed in 
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Tyrodes buffer containing 0.1% BSA.  Cells were labeled first with anti-FLAG-biotin antibody at 
0.2 µg/mL for 30-40 min, washed three times for 1 min in 1mL of buffer and labeled with 
quantum dot probe Qdot605-streptavidin conjugate at 100 pM for 10 min and then washed at 
least six times for 1 min in 1mL to remove unbound probe.  In some experiments, cells were 
treated with 0.1, 1 or 100 nM hCG for 1 hour.  Images were collected on a Zeiss Axiovert 200M 
microscope using a 63x 1.2 NA water objective and Qd605 filter set.  Images were collected 
every 100 ms for up to 2 minutes at a final magnification of 315x onto a CCD camera with 16 x 
16 µm pixels.  Image acquisition was performed with MetaMorph 7.1.6.  Determination of 
individual particle locations and the trajectories for individual particles were performed with 
Image J.  The diffusion coefficient and the domain size were calculated using a program 
developed by Dr. George Barisas at Colorado State University.  
 
2.8: Homo-Transfer FRET 
After hormone treatment with either luteinizing hormone (LH) or human chorionic 
gonadotropin (hCG), LH receptors are self-associated into dimers/oligomers and translocated 
into small membrane compartment (lipid rafts) where receptor motions are confined.  
Polarization homo FRET is one of the FRET techniques that has been used to investigate 
self-association of LH receptors.  The aggregation of LH receptors is related to hormone 
concentration as shown in a previous study using homo-FRET methods  which show a decrease 
in anisotropy when CHO cells are incubated with 100 nM hCG (43).  Homo-FRET is energy 
transfer between identical molecules, one acting as a donor and the other as an acceptor and this 
process can be assessed by imaging measurements of emission polarization.  Decreasing 
anisotropy indicates increased self-association of the LH receptor.  In this study, decreased 
anisotropy for wild type receptor after hormone treatment or mutant receptors defective in 
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hormone binding or signal transduction when co-expressed with wild type receptor was 
examined.   
 
2.9: Materials and cell culture 
           CHO (Chinese hamster ovary) cells were purchased from American Type Culture 
Collection (Manassas, VA).  CHO cells were maintained in high glucose Dulbecco’s 
Modification of Eagle’s Medium (DMEM).  DMEM medium was purchased from Corning 
Cellgro (Visalia, CA) supplemented with 10% fetal bovine serum (FBS).  FBS was purchased 
from Atlas Biologicals (Fort Collins, CO). Penicillin/streptomycin and L-glutamine solution 
were purchased from Gemini Bio-Products (West Sacramento, CA). 100x MEM non-essential 
amino acid solution and ethylenediamine tetraacetic acid (EDTA) were purchased from 
Sigma-Aldrich, Inc. (St. Louis, MO).  Human chorionic gonadotropin (hCG) was purchased 
from Fitzgerald Industries (Acton, MA) and prepared in 1x PBS.  Lipofectamine 3000 regent and 
OPTI-MEM reduced serum medium were purchased from Life Technology (Carlsbad, CA).  
Glass bottom cell culture dishes with 35 mm diameter and 14 mm diameter glass bottoms were 
purchased from Invitro Scientific (Sunnyvale, CA).  CHO cells were grown in 5% CO2 at 37°C 
in a humidified environment.  
 
2.10: Transfection of CHO cells with FLAG-LHR-YFP 
 CHO cells were grown in a 25 cm2 culture flask in DMEM medium supplemented with 
2mM L-glutamine, 10% fetal bovine serum (FBS), 1% penicillin/streptomycin and 1% 1x MEM 
non-essential amino acid solution. Cells were grown in 5% CO2 at 37°C in a humidified 
environment. CHO cells were transiently transfected with FLAG-LHR-YFP using Lipofectamine 
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3000 in accordance with the Manufacturer’s instructions. Two sterilized microcentrifuge tubes 
were needed, each containing 125μL of OPTI-MEM medium.  Tube one contained 5μL LP3000 
reagent and 0.4μg of FLAG-LHR-YFP.  Tube two contained 7.5μL of Lipofectamine 3000.  Tube 
one was added drop wise to tube two and the mixture was incubated at room temperature for 5 to 
15 min.  The mixture was added to CHO cells.  Cells were then plated in a 35mm glass-bottom 
Petri dish and grown to approximately 80% confluence in 1mL OPTI-MEM reduced serum 
medium.  Cells were maintained in a humidified incubator in 5% CO2 at 37°C.  Transfection 
proceeded for at least 24 hours. 
            CHO cells were transiently co-transfected with 0.4 µg FLAG-LHR-YFP and excess of 
HA-LHR-hCG,+cAMP or 0.4µg FLAG-LHR-YFP and excess of FLAG-LHR+hCG,-cAMP.  Co-transfection 
procedures were similar to those used to transfect CHO cells with FLAG-LHR-YFP above. 
 
2.11: Analysis of Polarization Homo-FRET 
            We investigated aggregation or self-association of LH receptors following hormone 
binding using polarized imaging microscopy to measure homo-FRET between receptors.  CHO 
cells, after transient transfection with wild type receptor FLAG-LHR-YFP alone or 
co-expressing FLAG-LHR-YFP with excess of either HA-LHR-hCG,+cAMPor FLAG-LHR+hCG,-cAMP 
were plated overnight in Willco 35 mm diameter #1.5 glass-bottom Petri dishes and grown to 
approximately 80-90 % confluence.  Cells were washed twice with 1x phosphate buffered saline 
(PBS) pH 7.0.  For untreated cells, the cells were incubated in 600 mL of PBS alone, while 
treated cells were incubated with different concentrations of hCG (0.1, 1 or 100 nM) at 37°C for 
one hour.  Cells were imaged on a Zeiss Axiovert 200M inverted microscope using a 63x 1.2 NA 
water objective and YFP filter set.  Images were acquired using an arc lamp for fluorescence 
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excitation with a polarized excitation filter.  Homo-transfer FRET data are collected from two 
separate images obtained using an Andor Du897E EMCCD camera and a “Dual View” image 
dissector.  This latter device provides simultaneous acquisition of separate images of 
fluorescence emission parallel to polarization of the excitation light and fluorescence 
perpendicular to excitation light, respectively. The cells were photobleached for 15 minutes and 
fluorescence emission was evaluated using MetaMorph 7.1.6.  Each anisotropy measurement 
was taken with g-factor and background images, and image analysis was performed with 
Image J.  Ten cells for each treatment were analyzed.  The fluorescence polarization anisotropy 
(r) was calculated using the following formula:   r = (I∥ -g  I⊥)/ (I∥ +2g I⊥) where g is the g-factor, 
and I∥, I⊥ are the parallel and perpendicular polarized emission intensities generated by excitation 
with vertically polarized light.   
 
2.12: EPAC-based FRET sensor 
            cAMP is a second messenger which regulates several cellular functions (69).  The cAMP 
sensor is based on Epac, an exchange protein directly activated by cAMP.  Several Epac-based 
probes, so-called ICUE probes, have used Epac1 and Epac2 as described by Zhang and 
colleagues (70).  Epac based reporter molecules can be used to evaluate intracellular cAMP 
levels by sandwiching the full length Epac between cyan fluorescence protein (CFP) as a donor 
and yellow fluorescence protein (YFP) as an acceptor.  Energy transfer FRET signals depend on 
the energy transferred from an excited donor to the FRET acceptor if both the donor and the 
acceptor are in close proximity.  With energy transfer, fluorescence emission from the excited 
donor will be reduced and fluorescence emission from the acceptor will increase.  In 
FRET-based sensors, binding of cAMP to Epac induces an unfolding of CFP and YFP domains 
which increases the distance between CFP and YFP.  The ratio of CFP emission to sensitized 
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YFP emission also increases (63).  In this study, we used ICUE3 to evaluate changes in cAMP in 
cells expressing LH receptors in response to hCG treatment.  
 
 2.13: Materials and cell culture 
           CHO (Chinese hamster ovary) cells were purchased from American Type Culture 
Collection (Manassas, VA).  CHO cells were maintained in high glucose Dulbecco’s 
Modification of Eagle’s Medium (DMEM).  DMEM medium was purchased from Corning 
Cellgro (Visalia, CA) supplemented with 10% fetal bovine serum (FBS).  FBS was purchased 
from Atlas Biologicals (Fort Collins, CO). Penicillin/streptomycin and L-glutamine solution 
were purchased from Gemini Bio-Products (West Sacramento, CA) and methyl-β-cyclodextrin 
(MβCD) was purchased from Sigma-Aldrich, Inc (St. Louis, MO). 100x MEM non-essential 
amino acid solution and ethylenediamine tetraacetic acid (EDTA) were purchased from 
Sigma-Aldrich, Inc. (St. Louis, MO).  Human chorionic gonadotropin (hCG) was purchased 
from Fitzgerald Industries (Acton, MA) and prepared in 1x PBS.  Lipofectamine 3000 regent and 
OPTI-MEM reduced serum medium were purchased from Life Technology (Carlsbad, CA).  35 
mm diameter glass-bottom cell culture dishes with 14 mm diameter glass-bottoms were 
purchased from Invitro Scientific (Sunnyvale, CA).  CHO cells were grown in 5% CO2 at 37°C 
in a humidified environment.    
 
2.14: Transfection of CHO cells with FLAG-LHR-YFP and ICUE3  
           CHO cells were grown in a 25 cm2 culture flask in DMEM medium supplemented with 
2mM L-glutamine, 10% fetal bovine serum (FBS), 1% penicillin/streptomycin and 1% 1x MEM 
non-essential amino acid solution. Cells were grown in 5% CO2 at 37°C in a humidified 
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environment. CHO cells were transiently co-transfected with FLAG-LHR-YFP and ICUE3 
plasmid kindly provided by Dr. Jin Zhang (Johns Hopkins University, Baltimore, USA) using 
Lipofectamine 3000 in accordance with the Manufacturer’s instructions. Two sterilized 
microcentrifuge tubes were needed, each one containing 125μL of OPTI-MEM medium.  Tube 
one contained 5μL LP3000 (reagent) and 0.4μg of FLAG-LHR-YFP.  Tube two contained 7.5μL 
of Lipofectamine 3000.  Tube one was added drop wise to tube two and the mixture was 
incubated at room temperature for 5 to 15 min.  Incubated mixture was added to the CHO cells, 
cells were plated in a 35mm glass-bottom Petri dish and grown to approximately 80% confluence 
in 1mL OPTI-MEM reduced serum medium.  Cells were maintained in a humidified incubator in 
5% CO2 at 37°C.  Transfection proceeded for at least 24 hours.  CHO cells were transiently co-
transfected with 0.4 µg ICUE3 and excess of HA-LHR-hCG,+cAMP and 0.4µg ICUE3 and excess of 
FLAG-LHR+hCG,-cAMP.  Co-transfection procedures were similar to those used to transfect CHO 
cells with FLAG-LHR-YFP and ICUE3 above.   
 
2.15: FRET measurement using dual emission ratio imaging 
            After cells were transiently transfected with ICUE3, ICUE3 and FLAG-LHR-YFP, 
ICUE3 and excess HA-LHR-hCG,+cAMP or ICUE3 and excess FLAG-LHR+hCG,-cAMP , medium was 
discarded from the Petri dish, cells were washed twice gently and maintained in 1x phosphate 
buffered saline (PBS) pH 7.4.  Cells were then immediately imaged.  Imaging data were 
collected using a 1.2 N.A. 63x water objective in a Zeiss Axiovert 200M inverted microscope 
with an EMCCD camera controlled by MetaFluor software.  A 10% neutral density filter was 
used to reduce the intensity of the arc lamp and reduce fluorophore photobleaching.  Emission 
ratios were obtained using a 436DF20 excitation filter, a 455 DRLP dichroic mirror, and two 
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emission filters, 480DF40 for CFP and 535DF30 for YFP.  All filters used were from Chroma 
Technology.  Images were taken at 60s intervals during acquisition and, for each experiment, a 
sequence of images were obtained.  During experiments, data were collected from untreated cells 
or pretreated cells for 1 hour with 10mM MβCD for several minutes before the PBS solution was 
removed and replaced with PBS containing 0.1, 1, or 100 nM hCG and cells were incubated for 
15 minutes at room temperature.  The data were analyzed using Image J software. Emission 
ratios (CFP/YFP) were calculated from CFP emission intensity and FRET emission intensity 
after background correction of fluorescent images.  These corrections were performed by 
subtracting the intensity of the background from the emission intensities of fluorescent cells 
expressing ICUE3.  
 
2.16: Statistical analysis of data 
 Mean values ± S.E.M. or standard deviation are presented.  Significance was evaluated 
using Student’s t-test and p values are indicated (p < 0.05). 
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CHAPTER 3: RESULTS 
 
3. 1: Introduction  
 
The data presented here were obtained from CHO cells expressing either wild  type 
receptor and/or mutant epitope-tagged receptors.  We also examined the effect of treatment with 
hCG, a hormone which has been previously demonstrated to cause aggregation of wild type LHR 
(71),  presumably through receptor cis-activation.  The goal of these studies was to determine 
whether lateral motions or the aggregation state of wild type or mutant receptors provided 
evidence of LHR trans-activation and, similarly, whether there was increased intracellular cAMP 
when CHO cells expressed a pair of receptors (FLAG-LHR+hCG,-cAMP or HA-LH-hCG,+cAMP) that 
could only function through receptor trans-activation.  
 




To assess the diffusion coefficient of LH receptors, we used single particle tracking 
methods to track the movements of single LH receptors on the plasma membrane of CHO cells 
expressing FLAG-LHR-YFP wild type receptors or coexpressing FLAG- LHR+hCG,-cAMP and  
HA-LHR-hCG,+cAMP.  Trajectories used to create MSD plots were obtained from FLAG-tagged 
receptors using images were recorded for two minutes.  A representative trace is shown in 
Figure 3.1 and samples of data obtained are shown in Table 3.1 and 3.2.  FLAG-LHR-YFP 
receptors before treatment with hCG had a microscopic diffusion coefficient (D0,1) of 2.70x10
-10 
± 1.05x10-10 cm2sec-1 (Table 3.3).  The domain size and the number of domains occupied by 
wild type receptors were 0.40 ± 0.15 μm and 5, respectively (Table 3.3).  The diffusion 
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coefficient D0,1 and domain size of wild type receptors treated with 100 nM hCG were reduced to 
1.51x10-10 ± 1.20x10-10 cm2sec-1 and 0.30 ± 0.20 µm, respectively.  The number of domains 
accessed by the receptor decreased to 3 (Table 3.3).                                                                                                  
The diffusion coefficient of mutant LH receptors FLAG-LHR+hC,-cAMP coexpressed with 
HA-LHR-hCG,+AMP before hormone hCG treatment was 8.76x10-10 ± 3.97x10-10 cm2sec-1.  The 
average domain size was 0.60 ± 0.43 µm and the number of domains was 5.  After 100 nM hCG 
treatment, the diffusion coefficient decreased to 2.35x10-10 ± 3.42x10-10 cm2sec-1.  The domain 
size and the number of domains also decreased to 0.37 ± 0.24 µm and 3, respectively (Table 
3.3).  This results suggests that HA-LHR-hCG,+AMP, a receptor which is unable to bind hCG, was 
nonetheless activated by FLAG-LHR+hCG,-cAMP.  In general, the diffusion coefficients measured, 
the size of domains occupied by receptors and the number of domains were reduced by treatment 
of cells with 100 nM hCG.  SPT raw data are presented in Appendix I. 
 
3.3: Effects of hCG treatment on aggregation of wild type FLAG-LHR-YFP, 
FLAG-LHR-YFP co-expressed with FLAG-LHR
+hCG,-cAMP
 or FLAG-LHR-YFP 
co-expressed with HA- LHR
-hCG,+cAMP
 
To examine the aggregation state of LH receptors in response to cis-activation or 
trans-activation by hCG treatment, we performed homo-transfer FRET experiments using CHO 
cells expressing wild type receptor FLAG-LHR-YFP,  FLAG-LHR-YFP co-expressed with 
FLAG-LHR+hCG,-cAMP or FLAG-LHR-YFP co-expressed with HA-LHR-hCG,+cAMP.   Homo-FRET 
was measured by imaging microscopy of polarized fluorescence from the YFP moiety attached 
to the C-terminus of FLAG-LHR-YFP.  When YFP moieties are in close proximity, presumably 
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due to receptor aggregation, the acceptor YFP molecules are oriented differently than donor YFP 
molecules and anisotropy is subsequently decreased.   
Hormone-treated LH receptors exhibited a higher degree of aggregation than did 
untreated LH receptors.  As shown in Table 3.4, change on photobleaching in mean anisotropy 
of wild type FLAG-LHR-YFP following 100 nM hCG treatment was 0.060 ± 0.003, larger and 
significantly different from the change on photobleaching in mean anisotropy for untreated cells 
which was 0.010 ± 0.001.  This suggests that receptor self-association accompanies 
cis-activation of wild type receptors in response to treatment of cells with increasing 
concentrations of hCG.   
The change on photobleaching in mean anisotropy of CHO cells coexpressing wild type 
receptor FLAG-LHR-YFP and FLAG-LHR+hCG,-AMP with a transfection ratio of 1:1 following 
100 nM hCG treatment was 0.100 ± 0.006 which was similar to the difference in mean 
anisotropy before hormone treatment, 0.100 ± 0.006.  The difference in mean anisotropy for cells 
coexpressing FLAG-LHR-YFP and FLAG-LHR+hCG,-AMP with a transfection ratio of 1:2 was 
0.090 ± 0.005 before 100 nM hCG treatment and 0.090 ± 0.006 after 100 nM hCG treatment.  
These values increased with a transfection ratio of 1:3 which resulted in a difference in mean 
anisotropy of 0.090 ± 0.007 before 100 nM hCG treatment and 0.120 ± 0.007 after cell treatment 
with 100 nM hCG.   
The changes on photobleaching in mean anisotropy between wild type receptor 
FLAG-LHR-YFP and the mutant receptor, FLAG-LHR+hCG,-AMP which binds hormone but is 
unable to initiate signal were likely to be the result of trans-activation by the wild type receptor.  
As shown in Table 3.4, CHO cells coexpressing FLAG-LHR-YFP and HA-LHR-hCG,+AMP , when 
the transfection ratio was 1:1, exhibited differences upon photobleaching in mean anisotropy of 
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0.070 ± 0.007 both before and after 100 nM hCG treatment.  The photobleaching-induced 
differences in mean anisotropy between this same receptor pair, FLAG-LHR-YFP and 
HA-LHR-hCG,+AMP  at a transfection ratio of 1:2 was 0.080 ± 0.004 after 100 nM hCG treatment,  
slightly larger than differences in mean anisotropy before hormone treatment of 0.070 ± 0.007.  
By increasing the transfection ratio for FLAG-LHR-YFP wt:HA-LHR-hCG,+AMP to 1:3, the 
photobleaching-induced difference in mean anisotropy following 100 nM hCG treatment was 
0.110 ± 0.007, somewhat larger than the differences in mean anisotropy for untreated cells.  
Overall, photobleaching induced differences in mean anisotropies values increased with an 
increase in the transfection ratio use for CHO cells co-expressing FLAG-LHR-YFP and either 
FLAG-LHR+hCG,-AMP or HA-LHR-hCG,+AMP (Table 3.4).  Examples of homo-FRET raw data are 
presented in Appendix II. 
 
3.4: Effects of hCG treatment on intracellular cAMP levels in CHO cells expressing 





            LH receptor-mediated changes in intracellular cAMP levels were measured following 
hCG treatment.  These studies used a live cell imaging technique to assess intramolecular 
hetero-FRET in ICUE3, a cAMP reporter molecule.  As shown in Table 3.5, the emission ratio 
of FLAG-LHR-YFP before hCG treatment was 0.85 ± 0.01 which increased after 100 nM hCG 
treatment to 0.89 ± 0.02.  This 1.05 fold increase in the ratio of CFP/YFPSE indicated 
cis-activation of wild type receptor by hCG.   
In CHO cells coexpressing mutant receptors FLAG-LHR+hCG,-AMP and HA-LHR-hCG,+AMP 
using a 1:1 transfection ratio, the CFP/YFP emission ratio before hormone hCG treatment was 
0.80 ± 0.01, a value that increased after 100 nM hCG treatment to 0.83 ± 0.01, a 1.03-fold 
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increase.  CHO cells coexpressing FLAG-LHR+hCG,-AMP and HA-LHR-hCG,+AMP , prepared using a 
transfection ratio of 1:10, had a CFP/YFP emission ratio before 100 nM hCG of 0.82 ± 0.01 and 
an emission ratio after 100 nM hCG treatment of 0.85 ± 0.01, a 1.04-fold change in the ratio of 
CFP to YFPSE emission.  Thus, increasing the transfection ratio for CHO cells co-expressing 
FLAG-LHR+hCG,-AMP and HA-LHR-hCG,+AMP increased the CFP/YFPSE emission ratio 
CFP/YFPSE upon treatment with 100 nM hCG although the changes were small.   
To assess effects of cholesterol depletion on intracellular cAMP levels in response to LH 
receptor mediated signaling, we pretreated CHO cells expressing FLAG-LHR-YFP or 
co-expressing FLAG-LHR+hCG,-AMP and HA-LHR-hCG,+AMP with MβCD as described in Chapter 
2.  As shown in Table 3.5, there was a significant decrease in the CFP/YFPSE emission ratio 
before and after 100 nM hCG treatment in cells expressing FLAG-LHR-YFP and pretreated with 
MβCD.  Before hormone treatment, the CFP to YFPSE ratio was 0.84 ± 0.01.  After hCG 
treatment, that ratio was 0.88 ± 0.02, a 1.04-fold increase.  CHO cells co-expressing 
FLAG-LHR+hCG,-AMP and HA-LHR-hCG,+AMP with transfection ratio of 1:1 and pretreated with 
MβCD had an emission ratio before 100 nM hCG treatment of 0.79 ± 0.01 which is identical to 
the emission ratio observed after hormone treatment.  The CFP to YFPSE emission ratio for 
CHO cells co-expressing both mutant receptors with transfection ratio of 1:10 and pre-treated 
with MβCD was 0.80 ± 0.01 before 100nM hCG treatment and 0.81 ± 0.01 after 100 nM hCG, a 
fold change of 1.01 (Table 3.5).  Figure 3.2 shows changes in the CFP to YFPSE ratio of CHO 
cells expressing FLAG-LHR-YFP untreated and treated with 100 nM hCG.  Examples of cAMP 









 Figure 3.1:  A representative trajectory (left panel) and MSD plot (right panel) for CHO cells 
 expressing FLAG-LHR-YFP and otherwise untreated.  The diffusion coefficient for this  



























FLAG-LHR-YFP  trajectory 

















MSD plot for  
FLAG-LHR-YFP   








Figure 3.2:  CFP/YFPSE ratio of CHO cells expressing FLAG-LHR-YFP and treated with 100 
nM hCG after 9 minutes. Images were collected for an additional 10 minutes after hCG 








Table 3.1: An example of a CSV file of a trajectory created from one image sequence.  Only a 

























CFP/YFPSE ratio of CHO cells expressing FLAG-LHR-YFP  
and treated with 100 nM hCG 
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frame y x 
      0 362.2074 103.6205 35 361.7089 103.3507 70 361.6321 103.3453 
1 361.7675 103.5363 36 361.7371 103.4365 71 361.7239 103.2666 
2 361.7477 103.48 37 361.7496 103.4086 72 361.6032 103.3174 
3 361.7124 103.4647 38 362.2369 103.4233 73 361.6386 103.2722 
4 362.2844 103.6019 39 361.6446 103.2604 74 361.6061 103.3162 
5 361.7488 103.5112 40 361.5998 103.3562 75 361.5644 103.3303 
6 361.7239 103.3871 41 361.7297 103.5121 76 361.5768 103.3217 
7 361.6636 103.5022 42 361.7597 103.362 77 361.5991 103.3607 
8 361.7643 103.4614 43 361.7054 103.3611 78 361.5637 103.366 
9 361.7119 103.4779 44 361.6674 103.4123 79 361.6145 103.3901 
10 361.7698 103.5175 45 361.7987 103.5439 80 361.4193 103.3601 
11 362.2305 103.4263 46 361.6517 103.4339 81 361.7131 103.4154 
12 362.226 103.4347 47 361.4847 103.2796 82 362.2495 103.479 
13 361.7216 103.5122 48 361.6284 103.4079 83 362.2681 103.4893 
14 361.658 103.4384 49 361.6579 103.5191 84 362.1398 103.5537 
15 361.6832 103.4498 50 361.6483 103.3974 85 
  16 362.3713 103.6831 51 361.6756 103.3978 86 361.58 103.3378 
17 362.2883 103.6753 52 361.4899 103.2473 87 361.7633 103.5013 
18 361.7733 103.6326 53 361.6345 103.3769 88 361.4713 103.3608 
19 361.6608 103.4836 54 361.5051 103.2661 89 361.5767 103.4489 
20 361.6614 103.355 55 361.6086 103.4446 90 361.7705 103.509 
21 361.7368 103.4377 56 361.6755 103.444 91 361.6429 103.3094 
22 361.6591 103.3342 57 361.7333 103.5169 92 361.2627 102.9066 
23 361.63 103.4107 58 361.6823 103.452 93 361.506 103.2816 
24 361.7461 103.4173 59 361.7072 103.525 94 361.6946 103.4288 
25 361.8057 103.5106 60 361.7647 103.3981 95 361.6197 103.4413 
26 361.6549 103.3493 61 361.756 103.4514 96 361.6233 103.3583 
27 361.683 103.3722 62 362.3722 103.5696 97 361.6447 103.4498 
28 361.5698 103.2961 63 361.6924 103.3799 98 361.6291 103.4127 
29 
  
64 362.3101 103.4804 99 361.6264 103.4456 
30 362.4957 103.5051 65 361.6812 103.4843 100 361.6353 103.5436 
31 362.1674 103.3978 66 361.7131 103.4792 101 361.6306 103.3703 
32 361.7772 103.3153 67 362.2311 103.5243 102 361.636 103.4506 
33 361.7458 103.3711 68 361.6142 103.3132 103 361.6092 103.3392 




Table 3.2: An example of the MSD file created from one image sequence.  Only a portion of     
the file is shown here. 
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i               gx               gy                gr     gxCalc      gyCalc 
                      
grCalc 
0 0 0 0 4.78E-03 4.78E-03 9.55E-03 
1 0.292361 4.87E-02 0.341017 0.967169 0.967169 1.934339 
2 0.425719 5.81E-02 0.48383 1.906026 1.906026 3.812051 
3 0.515722 6.77E-02 0.583413 2.827262 2.827262 5.654523 
4 0.565729 6.97E-02 0.635455 3.73404 3.73404 7.46808 
5 0.620122 7.28E-02 0.692972 4.628308 4.628308 9.256615 
6 0.642386 7.75E-02 0.719866 5.511398 5.511398 11.0228 
7 0.689937 8.10E-02 0.770959 6.38429 6.38429 12.76858 
8 0.716499 8.00E-02 0.796549 7.247747 7.247747 14.49549 
9 0.755532 8.15E-02 0.836992 8.10238 8.10238 16.20476 
10 0.772625 7.82E-02 0.850851 8.948695 8.948695 17.89739 
11 0.790256 0.079241 0.869497 9.78712 9.78712 19.57424 
12 0.798108 8.22E-02 0.880331 10.61802 10.61802 21.23605 
13 0.808814 0.082326 0.89114 11.44173 11.44173 22.88345 
14 0.83342 8.60E-02 0.919398 12.25851 12.25851 24.51702 
15 0.826448 8.66E-02 0.913003 13.06863 13.06863 26.13726 
16 0.873193 9.02E-02 0.96342 13.87231 13.87231 27.74462 
17 0.899003 9.39E-02 0.992915 14.66975 14.66975 29.3395 
18 0.935137 9.56E-02 1.030722 15.46115 15.46115 30.92229 
19 0.941703 9.52E-02 1.036899 16.24666 16.24666 32.49333 
20 0.908154 9.37E-02 1.001848 17.02646 17.02646 34.05292 
21 0.899741 9.55E-02 0.995287 17.80068 17.80068 35.60136 
22 0.898665 9.76E-02 0.996278 18.56946 18.56946 37.13891 
23 0.893185 9.45E-02 0.987728 19.33292 19.33292 38.66584 
24 0.876473 9.68E-02 0.973307 20.09118 20.09118 40.18236 
25 0.882438 9.61E-02 0.978564 20.84435 20.84435 41.6887 
26 0.881541 9.76E-02 0.979153 21.59254 21.59254 43.18507 
27 0.865226 0.101343 0.966569 22.33583 22.33583 44.67166 
28 0.8798 0.101781 0.981582 23.07432 23.07432 46.14865 
29 0.898224 0.104611 1.002835 23.80811 23.80811 47.61621 
30 0.903051 0.105444 1.008495 24.53726 24.53726 49.07452 
31 0.916402 0.103461 1.019863 25.26186 25.26186 50.52371 
32 0.944309 0.107579 1.051888 25.98198 25.98198 51.96396 
33 0.947188 0.10876 1.055947 26.69769 26.69769 53.39538 
34 0.935973 0.108833 1.044806 27.40906 27.40906 54.81812 
      
 
 Table 3.3: Effects of hCG on CHO cells expressed FLAG-LHR-YFP receptor or co-expressing 
FLAG-LHR+hCG/-cAMP and HA-LHR-hCG/+cAMP assessed by single particle tracking.  Data shown 



















10 None 2.70 ± 1.05
a  0.40 ±0.15d 5 ± 2 
FLAG-LHR-YFP wt 
 
10 0.1 4.17 ± 2.02
a  0.50 ±0.13d 5 ± 1 
FLAG-LHR-YFP wt 
 
10 1 1.89 ± 4.92
b  0.50 ±0.31e 3 ± 1 
FLAG-LHR-YFP wt 
 
10 100 1.51 ± 1.20
b  0.30 ±0.20e 2 ± 1 
  HA-LHR-hCG/+cAMP,  
FLAG-LHR+hCG/-cAMP 
 
11 None 8.76 ± 3.97c  0.60 ±0.43f 5 ± 1 
  HA-LHR-hCG/+cAMP,  
FLAG-LHR+hCG/-cAMP 
 
11 100 2.35 ± 3.42c  0.37 ±0.24f 3 ± 1 
   










Table 3.4: Homo-transfer FRET summary of wild type and mutant LH receptors expressed by 
CHO cells that were either untreated or treated with indicated concentrations of hCG.  Data 















FLAG-LHR-YFP  6 - 0.28 0.29 0.01 ± 0.01a,b 
6 0.1 nM 0.27 0.30 0.03 ± 0.01a 
8 1 nM 0.25 0.29 0.04 ± 0.01a 
8 100 nM 0.22 0.28 0.06 ± 0.01a 
FLAG-LHR-
YFP,   FLAG-
LHR+hCG,-cAMP 
1:1 10 - 0.20 0.30 0.10 ± 0.01b 
10 100 nM 0.17 0.27 0.10 ± 0.01b 
1:2 10 - 0.18 0.27 0.09 ± 0.01b 
10 100 nM 0.16 0.25 0.09 ± 0.01b 
1:3 10 - 0.17 0.26 0.09 ± 0.01b 
10 100 nM 0.13 0.25 0.12 ± 0.01b 
FLAG-LHR-
YFP,  HA- 
LHR-hCG,+cAMP 
1:1 10 - 0.26 0.33 0.07 ± 0.01b 
10 100 nM 0.22 0.29 0.07 ± 0.01b 
1:2 10 - 0.22 0.29 0.07 ± 0.01b 
10 100 nM 0.18 0.26 0.08 ± 0.01b 
1:3 10 - 0.23 0.32 0.10 ± 0.01b 
10 100 nM 0.21 0.32 0.11 ± 0.01b 
 
 * Values with different superscripts (a,b) differ significantly (p<0.05) 
 
 
Table 3.5: Effects of hCG treatment or MβCD pretreatment on CHO cells expressing wild type 
receptor FLAG-LHR-YFP or co-expressing LHR+hCG, -cAMP and LHR-hCG,+cAMP.  Data are shown 


































0.85 ± 0.01b 
 










0.84 ± 0.01b 
 
















0.80 ± 0.01a 
 







           




0.79 ± 0.01a 
 

















0.82 ± 0.01a 
 












0.80 ± 0.01a 
 









CHAPTER 4: DISCUSSION 
 
 
 Trans-activation of G protein-coupled receptors was described first for the epidermal 
growth factor receptor by Daub et al. (72).  Subsequent in vitro studies by a number of 
investigators showed that the glycoprotein hormone receptors including LH receptors and FSH 
receptors could induce signaling via receptor trans-activation (30,32,73,74).  Receptor 
trans-activation had the ability to rescue cAMP signaling despite deficiencies in the two 
receptors, one deficient in signaling and the other deficient in hormone binding, expressed in 
cells (30).  In fact, Ji et al. (30)  demonstrated that a hormone-occupied exodomain could trans-
activate an unliganded endodomain on an adjoining receptor using the proposed mechanism 
shown in Figure 4.1.  More recently, in vitro trans-activation of LH receptor has been 
demonstrated by Muller et al. (34). This was observed under conditions where a mutant LH 
receptor that could not initiate signal was co-expressed with an LH mutant receptor that could 
not bind hormone (75).  Importantly, reproductive function in animals was conserved using this 
mechanism despite the lack of a fully functional LH receptor. 
         Our data presented here outline the use of biophysical methods, including single particle 
tracking, homo-transfer FRET and hetero-transfer FRET, by means of which we have evaluated 
molecular interactions occurring during cis- and trans-activation of luteinizing 
hormone/chorionic gonadotropin receptors.  In this work, we specifically investigated whether 
cAMP signal increased in hormone-treated cells through cis-activation of wild type receptor and 
trans-activation of mutant receptors and whether signaling was accompanied by decreased 
diffusion of LH receptors and receptor aggregation.  We found that 100 nM hCG treatment 
increased cAMP levels in cells expressing the wild type receptor FLAG-LHR-YFP in response 
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to cis-activation of LH receptor (Table 3.5).  In addition, cAMP levels in cells expressing a pair 
of mutant receptors, FLAG-LHR+hCG/-cAMP and HA-LHR-hCG/+cAMP, was similarly increased after 
100 nM hCG treatment, a process that was dependent on the transfection ratio used to express 
the receptor pair (Table 3.5).  Our results agree with previous studies of hormone enhancement 
of cAMP levels for wild type and mutant LH receptors by Ji and coworkers (30).  
           Tae Ji’s initial description of LH receptor trans-activation used receptors pairs containing 
receptors with mutations in the leucine-rich repeat domains (LRRs) that introduced ligand 
binding defects coexpressed in the same cells were receptors containing mutations in exoloop 3 
and transmembrane domain 7 that resulted in signaling defects.  When co-expressed, these 
receptor pairs rescued cAMP production via trans-activation (30).  The most straightforward 
explanation for the successful cAMP rescue is that the exodomain of the receptor binds hormone 
which results in a hormone-exodomain complex which activates the endodomain of a nearby 
mutant receptor to generate cAMP signal (76).  Transgenic mice coexpressing mutant LH 
receptors where one receptor type was incapable of hormone binding and the other was incapable 
of inducing signal in the absence of wild type receptors exhibited rescued LH receptor function 
and induced cAMP signaling.  When each mutant receptor was expressed individually in cells, 
there was no cAMP signal generation.  Thus coexpressing two mutant receptors rescued cAMP 
signal by intermolecular activation, trans-activation, of the mutant receptors (75).  
Transactivation of a glycoprotein hormone receptor has also been demonstrated for the FSH 
receptor and, like LH receptors, involved co-expression of two different defective receptors, a 
non-binding mutant with intact signal generation, and another mutant that cannot generate signal 
but can bind hormone (32).  
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            Studies of interactions between LH receptors tagged with fluorescent proteins as donor or 
acceptor showed evidence of inter-receptor interactions (42).  Homo-FRET methods have been 
used to evaluate aggregation of LH receptor both by measuring absolute receptor anisotropies 
and by examining photobleaching-induced differences in emission anisotropy.  Receptor 
hetero-dimerization has been invoked to explain trans-activation of the receptor from several 
studies (75).  In one study, the Authors showed that activation occurs between a G-protein bound 
to the cytoplasmic tail of the inactive receptor and the intracellular domain of the active receptor, 
a process that could only be explained by dimerization of these receptors when one is active and 
the other is not  (77).                        
            Homo-FRET was used to evaluate interactions between either wild type 
FLAG-LHR-YFP receptors, between FLAG-LHR-YFP and FLAG-LHR+hCG/-cAMP, or between 
FLAG-LHR-YFP and HA-LHR-hCG/+cAMP receptors (Table 3.4).  We show that hormone-treated 
wild type receptors exhibit a high degree of aggregation in comparison with untreated LH 
receptors and that aggregation of wild type receptor when co-expressed with either mutant 
receptor increased in response to an increase in the ratio of receptor transfection.  This 
observation means that trans-activation is dependent on the ratio of mutant receptors as indicated 
in cAMP results.   
These data agree with a previous study showing increased aggregation of LH receptors 
following increases in hormone concentration (43).  Earlier studies by electron microscopy 
showed small groups of LH receptors on the cell surface of luteal cells after exposure of cells to 
high concentrations of LH (78).  Horvat et al. have measured FRET between FITC- and 
TrITC-derivatized hCG hormone bound to LH receptors (79).  Bioluminescence resonance 
energy transfer, BRET, which is sensitive to the distance and orientation between the donor and 
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acceptor has been used to assess aggregation or dimerization of LH receptors (80).  High order 
oligomers have been shown by homo-FRET for the GPCR serotonin 1A receptor.  In this system 
the initial anisotropy was reduced following receptor stimulation by its ligand, serotonin, in 
comparison with untreated receptors (39).   
Increased  differences between receptor final and  initial  fluorescence anisotropy values  
(Table 3.4) were accompanied by decreases in the diffusion coefficient of LH receptor following 
hormone  treatment  of either  wild  type  receptor FLAG-LHR-YFP or mutant  receptors  FLAG 
LHR+hCG/-cAMP and HA-LHR-hCG/+cAMP.  A previous study by Smith et al. has shown that binding 
of high concentrations of hCG to rat LH receptors leads to redistribution of LH receptors to 
cholesterol-rich membrane domains, that is, lipid rafts (51).  Rat LH receptors became 
aggregated and raft-associated following treatment with LH or hCG  (81).   
Unlike methods used in previous studies, single particle tracking (SPT) techniques 
measure the diffusion coefficient of individual LH receptors rather than that of a large population 
of receptors.  This allows us to analyze specific subpopulation of receptors that have specific 
diffusion properties (82).  Our data (Table 3.3) show that the average receptor diffusion 
coefficient following 100 nM hCG treatment, a concentration sufficient to saturate available LH 
receptors, for wild type receptors expressed on CHO cells or wild type receptors coexpressed 
with mutant receptors was about 10-11cm2s-1.  Following hormone treatment, the domain size and 
the number of domains were decreased for both FLAG-LHR-YFP wt and for mutant receptors 
FLAG-LHR+hCG/-cAMP and HA-LHR-hCG/+cAMP.  This agrees with previous studies of lateral 
diffusion of individual LH receptors where the average diffusion coefficient was reduced to 
about 10-12cm2s-1 following hormone treatment (82).   
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            Using SPT, we also observed a decrease in the receptor diffusion coefficient in response 
to increasing hCG concentrations for both wild type and mutant receptors.  This decrease in 
receptor lateral diffusion was accompanied by a corresponding increase in intracellular cAMP 
for hCG-treated wild type receptors and for mutant receptors when the transfection ratio was 
increased from 1:1 to 1:10.  This suggests that trans-activation between LHR+hCG/-cAMP and 
LHR-hCG/+cAMP receptors depends on the expression ratio of these receptors.  A single hormone-
binding mutant needs access to multiple copies of the hormone-binding, signaling-deficient 
mutant for successful interactions and signaling.  This agrees with previous measurements of 
diffusion coefficients of LH receptors on M17 neuroblastoma cells and levels of intracellular 
cAMP following hormone treatment when the activation of LH receptors resulted in decreased 
diffusion coefficients and increased levels of cAMP signal (82).   
            A variety of techniques have been used to examine the relationship between functional 
LH receptor and the environment of LH receptors membrane during cell signaling.  One of these 
methods required isolation of membrane microdomains that “float” in sucrose gradients.  
Receptors such as epidermal growth factor receptor, a plasma membrane receptor, are found in 
membrane rafts during signal transduction (83) and these membrane rafts have high 
concentrations of proteins necessary for signal transduction such as G-proteins (84).  In this work 
we used ICUE3 as an indicator of cAMP levels and measured cAMP levels following depletion 
of membrane cholesterol using MβCD for CHO cells expressing wild type receptor 
FLAG-LHR-YFP and co-expressing mutant receptors FLAG-LHR+hCG/-cAMP and 
HA-LHR-hCG/+cAMP with transfection ratios of 1:1 and 1:10.  These experiments were designed to 
assess the importance of membrane cholesterol in signal transduction (Table 3.5).  We found 
that there is a decrease in cAMP levels in cells expressing wild type receptors after pretreatment 
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with MβCD and exposure to 100 nM hCG.  When cells expressed mutant receptors arising from 
a transfection ratio of 1:1, the cAMP level was slightly decreased.  Increasing the transfection 
ratio to 1:10 for mutant receptors and pre-treating with MβCD caused further decreases in 
intracellular cAMP.   
The mechanism for this effect is not known.  Preincubation of LH receptor with MβCD 
to extract cholesterol from the plasma membrane is presumed to disrupt membrane rafts which 
work as signalplatforms  and thus  reduce cell signaling by  the receptor in response to hormone  
treatment, Interestingly, direct interaction with cholesterol and protein α-helices has been  
shown for β2-adrenergic receptor.  One possible role of cholesterol could be to force receptors to 
specific membrane regions where interactions with signaling components occurs (85).  The 
luteinizing hormone receptor (LH) has been shown to assemble in small membrane 
microdomains which are rich in cholesterol when the receptor is active, i.e. has bound ligand, 
which increases the molecular weight of the complex (79).  The disruption of these lipid rafts 
using MβCD decreases the signal produced by liganded receptors (86).  Diffusion coefficients 
for the LH receptor also decrease with hCG treatment (86) which agrees with our results for wild 
type receptors and mutant receptors where diffusion coefficient decrease and cAMP levels 
increased following hormone treatment.  These observations suggest that inducing cAMP 










Figure. 4.1. Proposed models of monomeric and dimeric cis-activation and trans-activation.  
Panel A shows the domain structure of LHR, including an exo-domain where the ligand binds 
and an endo-domain where the hormone signal is generated. Panel B shows cis- and trans-
activation of monomeric LHRs. The ligand is shown in red.   Panel C shows cis- and trans-
activation of dimeric LHRs. In trans-activation, the receptor dimer is formed by a hormone-








CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
 
 Functional LH receptors play an important role in reproductive function in females by 
enhancing ovulation and follicle maturation.  In this study, we demonstrated evidence of 
dimerization and/or oligomerization of LH receptors involved in trans-activation.  Our results 
suggest that, in addition to cis-activation of wild type receptor, trans-activation also occurs for 
mutant receptors where a receptor that cannot bind hormone is able to initiate signal when 
co-expressed with wild type receptors or mutant receptors that can bind hormone but cannot 
generate signal.  Our single particle tracking study shows a hormone-induced decrease in lateral 
diffusion of individual wild type receptors involved in cis-activation and of mutant receptors 
activated via trans-activation.   
 Further study of trans-activating LH receptor pairs could include an examination of 
HA-LHR-hCG/+cAMP lateral dynamics before and after hormone treatment when expressed together 
with FLAG-LHR+hCG/-cAMP.  These studies would be performed by single particle tracking of LH 
receptors on CHO cells co-expressing FLAG-LHR+hCG/-cAMP and HA-LHR-hCG/+cAMP, treated with 
hCG and labeled with anti-HA-biotin antibody for 30 min, washed and labeled with QD 
605-streptavidin.  Images would be collected on a Zeiss Axiovert 200M fluorescence microscopy 
using a 63x 1.2 NA water objective and Qd605 filter set.  We would expect to see decreased 
receptor diffusion coefficients, domain size and the number of domains occupied by 
HA-LHR-hCG/+cAMP if trans-activation by FLAG-LHR+hCG/-cAMP occurs.   
           We are also interested in the role of the cytoskeleton in transactivation of LH receptors.  A 
previous study of the lateral diffusion of LH receptor indicates that intact actin filaments may be 
needed for decreasing lateral motions of LH receptors in response to hormone (43).  It would be 
of interest to image actin filaments using fluorophore-tagged actin, for the same cell population, 
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and evaluate single particle tracking of cis- and trans-activated LH receptors.  CHO cells 
expressing either wild type LH or trans-activating LH receptor pairs would be treated with 
cytochalasin D to disrupt the actin filaments prior to hCG treatment.  We would expect to see an 
increase in the diffusion coefficient, domain size and number of domains for cis-activated wild 
type receptors.  It would be of interest to know whether one or both members of the trans-
activating receptor pair behave similarly to wild type LH receptors when microfilament 
structures are disrupted.   
            Previous studies have shown that LH receptors can exist as monomers as well as forming 
dimers or high order oligomers.  Our FRET study of wild type LH receptors demonstrates 
self-association or aggregation of LH receptors in response to cis-activation following hormone 
treatment.  The demonstration of LH mutant receptor dimerization/oligomerization resulting 
from the interaction between receptors suggests that the LH receptor can aggregate in the course 
of receptor trans-activation.  A future experiment would be using acceptor photobleaching FRET 
(hetero-FRET) to evaluate whether binding of hormone hCG to wild type FLAG-LHR-YFP or 
FLAG-LHR+hCG/-cAMP is accompanied by interactions with HA-LHR-hCG/+cAMP.  This experiment 
would evaluate FRET between receptors with a fluorescence donor such as CFP or a 
fluorescence acceptor such as YFP by measuring the intensity of the fluorescence donor in the 
presence and absence of a fluorescence acceptor.  CHO cells co-expressing FLAG-LHR-YFP 
and FLAG-LHR+hCG/-cAMP-CFP or FLAG-LHR-YFP and HA-LHR-hCG/+cAMP-CFP would be 
examined using an as described previously.  CFP and YFP would be imaged separately and YFP 
would then be irreversibly photobleached for five minutes.  After photobleaching, CFP and YFP 
would be imaged again.  The intensity of CFP signal after (Iafter) and before YFP photobleaching 
(Ibefore) would then used to evaluate energy transfer efficiency (%E).   Energy transfer efficiency 
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could be calculated as (1-Ibefore/Iafter)x100.  We would expect to see an increase in hetero-FRET 
efficiency resulting from receptor-receptor interactions between trans-activating receptor pairs 
and between wild type receptors if HA-LHR-hCG/+cAMP is trans-activated following binding of 
hCG to wild type receptors LHR+hCG/+cAMP.   We would then use ICUE3 to determine whether 
LH receptor trans-activation has produced increased cell signaling.  These experiments would 
need to take into account our observation in this project that trans-activation of mutant LH 
receptors is dependent on the ratio of mutant receptors and requires an excess of the “hormone 
binding, non-signaling” receptor.    
 Lastly, cholesterol depletion of LH receptor resulted in a decrease in hormone-induced 
cAMP levels.  Hence we conclude that cholesterol is important for signal transduction by LH 
receptor.  We could perform single particle tracking studies as a future experiment for CHO cells 
expressing FLAG-LHR-YFP wt or co-expressing HA-LHR-hCG/+cAMP and FLAG- LHR+hCG/-cAMP 
after cholesterol depletion using 10 mM MβCD at 37°C for 1 hour to evaluate the interactions 
between receptors and confinement in small membrane microdomains in cholesterol-depleted 
cell membranes.  We would expect to see faster receptor diffusion and disruption of membrane 
microdomains with cholesterol depletion.    
           In conclusion, these experiments have provided a better understanding of cis- and trans-
activation of the LH receptor in response to hCG.  Such understanding of the mechanisms 
involved in signaling by functional LH receptors or, more generally GPCR, will be helpful in 
designing drug treatments for diseases where modulation of receptor-mediated signal generation 
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APPENDIX I: Data Analysis for Single Particle Tracking 
 
Table A1: Diffusion coefficient of untreated CHO cells expressed FLAG-LHR-YFP (p1)  
param value 
 
FUNCTION AkiDisp(w,t,D)  
    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 
re-derived and checked against early Kusumi 
paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    nPts= 323 
 
w is width of domain (n cells orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of 




     sumWtdResid= 4893.28 
 
ELSE 
      
chiSq= 0.094096127 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.306750921 
 
w (pix)= 1.65E+00 
D (pix^2/frame)= 2.745011789 
m(pix^2/frame) 6.02804754E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
  w(um)= 0.4190 
D01(cm^2/sec)= 3.13E-10 
Dhop(cm^2/sec)= 3.24E-12 







0 200 400 600 800 1000 
69 





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 595 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of 




     sumWtdResid= 3760.25 
 
ELSE 
      
chiSq= 0.021854447 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.147832495 
 
 w (pix)= 2.01E+00 






   um per pixel= 16 
 mag 
(obj*Extender)= 63 
 sec per frame= 0.12 
 
   w(um)= 0.5093 
 D01(cm^2/sec)= 2.74E-10 
 Dhop(cm^2/sec)= 2.23E-13 
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multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    nPts= 1000 
 
w is width of domain (n cells orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of 




     sumWtdResid= 9798.35 
 
ELSE 
      
chiSq= 0.026216391 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.161914764 
 
 w (pix)= 1.97E+00 






   um per pixel= 16
 mag 
(obj*Extender)= 63 
 sec per frame= 0.12 
 
   w(um)= 0.4998
 D01(cm^2/sec)= 3.50E-10 
        Dhop(cm^2/sec)= 1.17E-11 
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multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 559 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 




     sumWtdResid= 331076.70 
 
ELSE 
      
chiSq= 2.14802146 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 





      w (pix)= 1.80E+00 
        D (pix^2/frame)= 7.27914E-07 




        
          um per pixel= 16 
        mag 
(obj*Extender)= 63 
        sec per frame= 0.12 
        
          w(um)= 0.4568 
        D01(cm^2/sec)= 4.33E-10 
        Dhop(cm^2/sec)= 3.64E-11 
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FUNCTION AkiDisp(w,t,D)  
    
   
multi-expon approx to 1D diff confined 
in region of width w 
 
g Column= D 
 
re-derived and checked against early Kusumi 
paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    nPts= 417 
 
w is width of domain (n cells orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps 




     sumWtdResid= 992.06 
 
ELSE 




diffusion for a time t with <r2> in cm2 
SD= 0.106946956 
 
w (pix)= 1.35E+00 
D (pix^2/frame)= 0.070474342 
m(pix^2/frame) 6.18111733E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
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multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 1000 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of 




     sumWtdResid= 217.03 
 
ELSE 
      
chiSq= 0.000580674 
 
Tau=w^2/(pi^2*D)'continuous diffusion for 
a time t with <r2> in cm2 
SD= 0.024097181 
 
w (pix)= 7.17E-01 
D (pix^2/frame)= 0.001808873 
m(pix^2/frame) 2.46416691E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
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multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    nPts= 964 
 
w is width of domain (n cells orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 467.98 
 
ELSE 
      
chiSq= 0.001315205 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a time 
t with <r2> in cm2 
SD= 0.036265758 
 
w (pix)= 1.08E+00 




  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
  w(um)= 0.2749 
D01(cm^2/sec)= 2.98E-10 
Dhop(cm^2/sec)= 2.49E-12 
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multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 750 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 




     sumWtdResid= 105812.69 
 
ELSE 
      
chiSq= 0.424526031 
 
Tau=w^2/(pi^2*D)'continuous diffusion for 
a time t with <r2> in cm2 
SD= 0.651556621 
 
w (pix)= 3.70E+00 
D (pix^2/frame)= 0.004014622 
m(pix^2/frame) 7.18298774E-07 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
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multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    nPts= 750 
 
w is width of domain (n cells orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 




     sumWtdResid= 210.70 
 
ELSE 
      
chiSq= 0.000845323 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.029074434 
 
w (pix)= 3.00E+00 
D (pix^2/frame)= 7.18089E-05 
m(pix^2/frame) 3.81569709E-05 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
  w(um)= 0.7619 
D01(cm^2/sec)= 2.77E-12 
Dhop(cm^2/sec)= 2.05E-13 
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Table A10: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 
1nM hCG (p3) 
param value      
FUNCTION 
AkiDisp(w,t,D)  
    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 750 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 




     sumWtdResid= 10.70 
 
ELSE 
      
chiSq= 4.29365E-05 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.006552596 
 
w (pix)= 5.00E-01 
D (pix^2/frame)= 0.000343875 
m(pix^2/frame) 1.29676594E-05 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
  w(um)= 0.1270 
D01(cm^2/sec)= 7.60E-12 
Dhop(cm^2/sec)= 6.97E-14 
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Table A11: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 





    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 120 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 2.61 
 
ELSE 
      
chiSq= 4.96213E-05 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a time 
t with <r2> in cm2 
SD= 0.007044235 
 
w (pix)= 1.00E+00 
D (pix^2/frame)= 0.000376393 
m(pix^2/frame) 6.38576225E-05 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
          w(um)= 0.2540 
        D01(cm^2/sec)= 1.20E-11 
        Dhop(cm^2/sec)= 3.43E-13 
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Table A12: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 





    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    nPts= 145 
 
w is width of domain (n cells orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 15.53 
 
ELSE 
      
chiSq= 0.001487421 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a time 
t with <r2> in cm2 
SD= 0.038567092 
 
w (pix)= 4.48E-01 
D (pix^2/frame)= 0.047585985 
m(pix^2/frame) 3.75191232E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
  w(um)= 0.1137 
D01(cm^2/sec)= 8.27E-11 
Dhop(cm^2/sec)= 7.27E-12 
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Table A13: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 





    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 138 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 




     sumWtdResid= 1674.03 
 
ELSE 
      
chiSq= 0.177089349 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.420819853 
 
 w (pix)= 2.88E+00 
 D (pix^2/frame)= 1.111206291 
 m(pix^2/frame) 1.02861292E-03 
 
   um per pixel= 16 
 mag 
(obj*Extender)= 63 
 sec per frame= 0.12 
 
   w(um)= 0.7323 
 D01(cm^2/sec)= 2.74E-09 
 Dhop(cm^2/sec)= 5.53E-12 
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Table A14: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 750 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 4801.58 
 
ELSE 
      
chiSq= 0.019264205 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a time t 
with <r2> in cm2 
SD= 0.13879555 
 
w (pix)= 3.00E+00 




  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
  w(um)= 0.1619 
D01(cm^2/sec)= 1.11E-11 
Dhop(cm^2/sec)= 2.94E-15 










0 200 400 600 800 1000 
82 
Table A15: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 





    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    nPts= 418 
 
w is width of domain (n cells orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 6888.47 
 
ELSE 
      
chiSq= 0.079038871 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a time 
t with <r2> in cm2 
SD= 0.281138527 
 
 w (pix)= 1.35E+00 
 D (pix^2/frame)= 5.76964E-07 
 m(pix^2/frame) 3.24127888E-03 
 
   um per pixel= 16 
 mag 
(obj*Extender)= 63 
 sec per frame= 0.12 
 
   w(um)= 0.3437 
 D01(cm^2/sec)= 2.20E-10 
 Dhop(cm^2/sec)= 1.74E-11 
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Table A16: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 





    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 183 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 726.88 
 
ELSE 
      
chiSq= 0.043648649 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.208922592 
 
w (pix)= 1.30E+00 
D (pix^2/frame)= 0.095737255 
m(pix^2/frame) 2.60947081E-03 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
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Table A17: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 





    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 210 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 




     sumWtdResid= 1340.83 
 
ELSE 
      
chiSq= 0.061099749 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.247183635 
 
w (pix)= 1.50E+00 
D (pix^2/frame)= 0.407616657 
m(pix^2/frame) 8.47554682E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
  w(um)= 0.3810 
D01(cm^2/sec)= 6.59E-10 
Dhop(cm^2/sec)= 1.64E-11 
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Table A18: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 903 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1




     sumWtdResid= 5718.53 
 
ELSE 
      
chiSq= 0.017571528 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a
time t with <r2> in cm2 
SD= 0.132557641 
 
 w (pix)= 1.93E+00 
 D (pix^2/frame)= 0.00530133 
 m(pix^2/frame) 1.01467117E-04 
 
   um per pixel= 16 
 mag 
(obj*Extender)= 63 
 sec per frame= 0.12 
 
   w(um)= 0.4895 
 D01(cm^2/sec)= 7.79E-10 
 Dhop(cm^2/sec)= 5.45E-13 
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Table A19: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 750 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 1023.89 
 
ELSE 
      
chiSq= 0.004107898 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.064092884 
 
w (pix)= 3.00E+00 
D (pix^2/frame)= 0.000283191 
m(pix^2/frame) 1.33444733E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
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Table A20: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 





    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 367 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 11310.30 
 
ELSE 
      
chiSq= 0.168405747 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 




w (pix)= 2.00E+00 
 D (pix^2/frame)= 0.018243018 
 m(pix^2/frame) 1.77447436E-07 
 
   um per pixel= 16 
 mag 
(obj*Extender)= 63 
 sec per frame= 0.12 
 
   w(um)= 0.5079 
 D01(cm^2/sec)= 2.52E-10 
 Dhop(cm^2/sec)= 9.54E-16 
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Table A21: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 850 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 




     sumWtdResid= 4874.94 
 
ELSE 
      
chiSq= 0.016301489 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.127677286 
 
w (pix)= 2.13E+00 
D (pix^2/frame)= 0.02404313 
m(pix^2/frame) 8.36658587E-05 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
  w(um)= 0.5413 
D01(cm^2/sec)= 4.64E-10 
Dhop(cm^2/sec)= 4.50E-13 
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Table A22: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 100 





    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 925 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of 




     sumWtdResid= 5496.97 
 
ELSE 
      
chiSq= 0.016340615 
 
Tau=w^2/(pi^2*D)'continuous diffusion for 
a time t with <r2> in cm2 
SD= 0.127830416 
 
w (pix)= 1.20E+00 
D (pix^2/frame)= 0.07800169 
m(pix^2/frame) 1.28397312E-03 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
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Table A23: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 100 





    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 919 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of 




     sumWtdResid= 1532.26 
 
ELSE 
      
chiSq= 0.004595703 
 
Tau=w^2/(pi^2*D)'continuous diffusion for 
a time t with <r2> in cm2 
SD= 0.067791615 
 
w (pix)= 2.19E+00 
D (pix^2/frame)= 0.001522389 
m(pix^2/frame) 6.66937031E-07 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
  w(um)= 0.5559 
D01(cm^2/sec)= 1.84E-10 
Dhop(cm^2/sec)= 3.58E-15 
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Table A24: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 100 





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 1000 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of 




     sumWtdResid= 1024.46 
 
ELSE 
      
chiSq= 0.002741039 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.052354931 
 
w (pix)= 6.00E-01 
D (pix^2/frame)= 0.001812308 
m(pix^2/frame) 2.46731711E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
  w(um)= 0.1524 
D01(cm^2/sec)= 6.98E-11 
Dhop(cm^2/sec)= 1.33E-12 
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Table A25: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 100 
nM hCG  (p4) 





    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 346 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 




     sumWtdResid= 19969.66 
 
ELSE 
      
chiSq= 0.33458424 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.578432572 
        w (pix)= 5.00E-01 
 
 
D (pix^2/frame)= 11.87915042 
 m(pix^2/frame) 5.99516731E-04 
 
   um per pixel= 16 
 mag 
(obj*Extender)= 63 
 sec per frame= 0.12 
 
   w(um)= 0.1270 
 D01(cm^2/sec)= 1.15E-10 
 Dhop(cm^2/sec)= 3.22E-12 
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Table A26: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 100 





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 101 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 




     sumWtdResid= 80.97 
 
ELSE 
      
chiSq= 0.016034031 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.126625556 
 
w (pix)= 1.57E+00 
D (pix^2/frame)= 0.004543118 
m(pix^2/frame) 6.18349081E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
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Table A27: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 100 






    
   
multi-expon approx to 1D diff confined 
in region of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    nPts= 702 
 
w is width of domain (n cells orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of 




     sumWtdResid= 20866.56 
 
ELSE 
      
chiSq= 0.092598287 
 
Tau=w^2/(pi^2*D)'continuous diffusion for 
a time t with <r2> in cm2 
SD= 0.304299666 
 
w (pix)= 1.70E+00 
D (pix^2/frame)= 0.002037065 
m(pix^2/frame) 2.21349152E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.12 
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Table A28: Diffusion coefficient of CHO cells expressed FLAG-LHR-YFP and treated with 100 





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 1000 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of 




     sumWtdResid= 2014.68 
 
ELSE 




for a time t with <r2> in cm2 
SD= 0.073419804 
 
w (pix)= 1.97E+00 
D (pix^2/frame)= 0.002712664 
m(pix^2/frame) 1.98532253E-07 
  um per pixel= 16
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
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Table A29: Diffusion coefficient of untreated CHO cells coexpressed mutant receptors of FLAG-





     
   
multi-expon approx to 1D diff confined in 
region of width w 
  
g Column= D 
 
re-derived and checked against 
early Kusumi paper 
   
iDim= 2 
 
accurate to 1:1000 @ 
t=0 
     
nPts= 194 
 
w is width of domain (n cells 
orig) 
    iFirstRow= 1 
 
t is time (i jumps orig) 
     iLastRow= 500 
 
D is diffusion coeff 
      
   
IF D=0 THEN     'diffusion for t steps of 
length 1 with <r2>in steps^2 
 sumWts= 18721.0000 
 
Tau=(2*w^2)/(pi^2) 
      sumWtdResid= 48.55 
 
ELSE 
       
chiSq= 0.00259346 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
 SD= 0.050926029 
 
w (pix)= 1.00E+00 
D (pix^2/frame)= 0.906092354 
m(pix^2/frame) 7.17258340E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
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Table A30: Diffusion coefficient of untreated CHO cells coexpressed mutant receptors of FLAG-





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 225 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 6838.56 
 
ELSE 
      
chiSq= 0.271371443 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.520933242 
 
w (pix)= 1.05E+00 
D (pix^2/frame)= 1.642650126 
m(pix^2/frame) 7.18404383E-03 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
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Table A31: Diffusion coefficient of untreated CHO cells coexpressed mutant receptors of FLAG-





    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 153 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 903.61 
 
ELSE 
      
chiSq= 0.077710243 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a time t 
with <r2> in cm2 
SD= 0.278765569 
 
w (pix)= 2.63E+00 
D (pix^2/frame)= 0.929512055 
m(pix^2/frame) 4.00797978E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
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Table A32: Diffusion coefficient of untreated CHO cell coexpressed mutant receptors of FLAG-





    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 118 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 1341.99 
 
ELSE 
      
chiSq= 0.194407355 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.440916494 
 
w (pix)= 1.80E+00 
D (pix^2/frame)= 1.198744834 
m(pix^2/frame) 3.68662280E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
  w(um)= 0.4571 
D01(cm^2/sec)= 6.02E-10 
Dhop(cm^2/sec)= 7.14E-12 
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Table A33: Diffusion coefficient of untreated CHO cell coexpressed mutant receptors of FLAG-





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 367 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of 




     sumWtdResid= 43272.22 
 
ELSE 
      
chiSq= 0.644305807 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.802686618 
 
w (pix)= 3.44E+00 
D (pix^2/frame)= 1.03472486 
m(pix^2/frame) 1.71220312E-03 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
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Table A34: Diffusion coefficient of untreated CHO cell coexpressed mutant receptors of FLAG-





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 185 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 




     sumWtdResid= 3505.36 
 
ELSE 
      
chiSq= 0.20595547 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.453823171 
 
w (pix)= 2.25E+00 
D (pix^2/frame)= 1.305288786 
m(pix^2/frame) 2.16840124E-03 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
  w(um)= 0.5718 
D01(cm^2/sec)= 8.21E-10 
Dhop(cm^2/sec)= 4.20E-11 
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Table A35: Diffusion coefficient of untreated CHO cell coexpressed mutant receptors of FLAG-





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 182 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of 




     sumWtdResid= 722.23 
 
ELSE 
      
chiSq= 0.0438486 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.209400574 
 
w (pix)= 2.31E+00 
D (pix^2/frame)= 1.088064527 
m(pix^2/frame) 1.13258958E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
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Table A36: Diffusion coefficient of CHO cell coexpressed mutant receptors of FLAG-LHR+hCG/-





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 111 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 




     sumWtdResid= 3.96 
 
ELSE 
      
chiSq= 0.000648199 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.025459749 
 
 w (pix)= 8.65E-01 
 D (pix^2/frame)= 0.266354025 
 m(pix^2/frame) 1.91578482E-04 
 
   um per pixel= 16 
 mag 
(obj*Extender)= 63 
 sec per frame= 0.0333 
 
   w(um)= 0.2196 
 D01(cm^2/sec)= 2.06E-10 
 Dhop(cm^2/sec)= 3.71E-1 
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Table A37: Diffusion coefficient of CHO cell coexpressed mutant receptors of FLAG-LHR+hCG/-





     
   
multi-expon approx to 1D diff confined in 
region of width w 
  
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
   
iDim= 2 
 
accurate to 1:1000 @ 
t=0 
     
nPts= 582 
 
w is width of domain (n cells 
orig) 
    iFirstRow= 1 
 
t is time (i jumps orig) 
     iLastRow= 500 
 
D is diffusion coeff 
      
   
IF D=0 THEN     'diffusion for t steps of length 1 
with <r2>in steps^2 
 sumWts= 165585.0000 
 
Tau=(2*w^2)/(pi^2) 
      sumWtdResid= 714.93 
 
ELSE 
       
chiSq= 0.004317624 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
 SD= 0.065708631 
 
w (pix)= 6.25E-01 
D (pix^2/frame)= 0.306715771 
m(pix^2/frame) 6.81926764E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 

















0 200 400 600 800 1000 
105 
Table A38: Diffusion coefficient of CHO cell coexpressed mutant receptors of FLAG-LHR+hCG/-





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 206 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 4.68 
 
ELSE 
      
chiSq= 5.74046E-05 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a time 
t with <r2> in cm2 
SD= 0.007576581 
 
w (pix)= 4.90E-01 
D (pix^2/frame)= 0.056586347 
m(pix^2/frame) 3.52607706E-05 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
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Table A39: Diffusion coefficient of CHO cell coexpressed mutant receptors of FLAG-LHR+hCG/-





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 305 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 585.60 
 
ELSE 
      
chiSq= 0.012631658 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.11239065 
 
w (pix)= 1.20E+00 
D (pix^2/frame)= 0.058970009 
m(pix^2/frame) 3.84624612E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
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Table A40: Diffusion coefficient of CHO cell coexpressed mutant receptors of FLAG-LHR+hCG/-





    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 565 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 2594.22 
 
ELSE 
      
chiSq= 0.016511155 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.128495741 
 
w (pix)= 1.00E+00 
D (pix^2/frame)= 8.81129E-07 
m(pix^2/frame) 9.11639849E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
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Table A41: Diffusion coefficient of CHO cell coexpressed mutant receptors of FLAG-LHR+hCG/-






    
   
multi-expon approx to 1D diff confined in region 
of width w 
 
g Column= D 
 
re-derived and checked against early 
Kusumi paper 
  iDim= 2 
 
accurate to 1:1000 @ t=0 
    
nPts= 569 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of length 1 




     sumWtdResid= 7327.22 
 
ELSE 
      
chiSq= 0.046051023 
 
Tau=w^2/(pi^2*D)'continuous diffusion for a 
time t with <r2> in cm2 
SD= 0.214595021 
 
w (pix)= 1.90E+00 
D (pix^2/frame)= 0.009421452 
m(pix^2/frame) 3.69618416E-06 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
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Table A42: Diffusion coefficient of CHO cell coexpressed mutant receptors of FLAG-LHR+hCG/-






    
   
multi-expon approx to 1D diff confined in 
region of width w 
 
g Column= D 
 





accurate to 1:1000 @ 
t=0 
    
nPts= 778 
 
w is width of domain (n cells 
orig) 
   iFirstRow= 1 
 
t is time (i jumps orig) 
    iLastRow= 500 
 
D is diffusion coeff 
     
   
IF D=0 THEN     'diffusion for t steps of 




     sumWtdResid= 621.71 
 
ELSE 
      
chiSq= 0.002362197 
 
Tau=w^2/(pi^2*D)'continuous diffusion for 
a time t with <r2> in cm2 
SD= 0.048602443 
 
w (pix)= 3.73E-01 
D (pix^2/frame)= 0.499855715 
m(pix^2/frame) 3.87332418E-04 
  um per pixel= 16 
mag 
(obj*Extender)= 63 
sec per frame= 0.0333 
  w(um)= 0.0946 
D01(cm^2/sec)= 5.93E-11 
Dhop(cm^2/sec)= 7.50E-12 















Table B1: Homo FRET of untreated CHO cells expressed wild type receptor FLAG-LHR-YFP  
T 




Ihbg Ivc s r 
0 1.41 392.309 362.658 330.564 340.505 61.745 22.153 31.23573 124.2165 0.245614 
1 1.41 362.626 347.025 328.209 334.89 34.417 12.135 17.11035 68.6377 0.252145 
2 1.41 353.95 342.82 327.693 333.723 26.257 9.097 12.82677 51.91054 0.258719 
3 1.41 350.99 341.388 326.943 333.096 24.047 8.292 11.69172 47.43044 0.260493 
4 1.41 347.805 339.741 327.219 332.848 20.586 6.893 9.71913 40.02426 0.271507 
5 1.41 345.837 339.211 327.211 333.023 18.626 6.188 8.72508 36.07616 0.274445 
6 1.41 344.959 338.35 327.025 332.4 17.934 5.95 8.3895 34.713 0.274955 
7 1.41 343.915 338.262 327.035 332.644 16.88 5.618 7.92138 32.72276 0.273773 
8 1.41 343.339 338.008 327.004 332.47 16.335 5.538 7.80858 31.95216 0.26685 
9 1.41 341.197 336.691 326.839 331.842 14.358 4.849 6.83709 28.03218 0.268296 
10 1.41 340.253 336.378 326.092 331.717 14.161 4.661 6.57201 27.30502 0.277934 
11 1.41 339.289 335.117 325.268 330.514 14.021 4.603 6.49023 27.00146 0.278902 
12 1.41 338.373 334.434 324.951 330.215 13.422 4.219 5.94879 25.31958 0.295155 
13 1.41 337.694 334.358 324.624 330.156 13.07 4.202 5.92482 24.91964 0.286729 
14 1.41 336.444 333.538 324.542 329.92 11.902 3.618 5.10138 22.10476 0.307654 





































Table B2: Homo FRET of CHO cells expressed wild type receptor FLAG-LHR-YFP and treated 
with 0.1 nM hCG 
 




ihbg ivc s r 
0 0.8 381.371 380.315 362.984 368.836 18.387 11.479 9.1832 36.7534 0.25042 
1 0.8 378.336 376.687 359.475 365.125 18.861 11.562 9.2496 37.3602 0.25726 
2 0.8 377.19 375.615 359.77 364.984 17.42 10.631 8.5048 34.4296 0.25894 
3 0.8 375.961 374.785 358.08 363.979 17.881 10.806 8.6448 35.1706 0.26261 
4 0.8 375.571 374.94 356.903 363.852 18.668 11.088 8.8704 36.4088 0.2691 
5 0.8 374.628 374.406 359.607 365.754 15.021 8.652 6.9216 28.8642 0.28060 
6 0.8 373.894 373.45 358.295 364.489 15.599 8.961 7.1688 29.9366 0.28160 
7 0.8 373.995 373.839 358.377 364.475 15.618 9.364 7.4912 30.6004 0.26557 
8 0.8 373.016 373.457 357.328 364.59 15.688 8.867 7.0936 29.8752 0.28767 
9 0.8 372.972 373.823 355.361 363.492 17.611 10.331 8.2648 34.1406 0.27375 
10 0.8 369.689 366.295 355.738 358.262 13.951 8.033 6.4264 26.8038 0.28072 
11 0.8 374.831 377.57 361.508 369.689 13.323 7.881 6.3048 25.9326 0.27063 
12 0.8 373.456 375.366 360.639 367.93 12.817 7.436 5.9488 24.7146 0.27790 
13 0.8 373.214 375.291 358.262 366.785 14.952 8.506 6.8048 28.5616 0.28525 
14 0.8 373.193 374.212 357.393 365.295 15.8 8.917 7.1336 30.0672 0.28823 
15 0.8 373.626 375.92 359.115 368.121 14.511 7.799 6.2392 26.9894 0.30648 














Figure B2: Increasing receptor anisotropy upon photobleaching of CHO cells expressing 























Table B3: Homo FRET of CHO cells expressed wild type receptor FLAG-LHR-YFP and treated 
with 1 nM hCG 
 
t  




Ihbg Ivc s r 
0 0.8 429.203 419.322 391.327 393.846 37.876 25.476 20.3808 78.6376 0.22248 
1 0.8 423 412.671 387.173 389.327 35.827 23.344 18.6752 73.1774 0.23439 
2 0.8 422.615 413.318 387.077 389.318 35.538 24 19.2 73.938 0.22097 
3 0.8 422.566 413.451 386.981 389.098 35.585 24.353 19.4824 74.5498 0.21600 
4 0.8 421.783 412.626 387.192 388.808 34.591 23.818 19.0544 72.6998 0.21371 
5 0.8 423.042 414.654 388.673 391.962 34.369 22.692 18.1536 70.6762 0.22943 
6 0.8 420.689 411.164 386.615 388.596 34.074 22.568 18.0544 70.1828 0.22826 
7 0.8 421.252 416.014 390.154 395.769 31.098 20.245 16.196 63.49 0.23471 
8 0.8 420.052 415.51 386.846 393.865 33.206 21.645 17.316 67.838 0.23423 
9 0.8 420.476 414.259 388.154 393.019 32.322 21.24 16.992 66.306 0.23120 
10 0.8 416.996 411.192 386.019 391.519 30.977 19.673 15.7384 62.4538 0.24400 
11 0.8 420.874 418.538 391.288 399.173 29.586 19.365 15.492 60.57 0.23269 
12 0.8 418.937 418.434 390.062 399.935 28.875 18.499 14.7992 58.4734 0.24072 
13 0.8 416.066 413.892 386.673 395.712 29.393 18.18 14.544 58.481 0.25391 
14 0.8 414.748 413.315 387.212 396.462 27.536 16.853 13.4824 54.5008 0.25786 
15 0.8 413.741 414.815 383.404 396.519 30.337 18.296 14.6368 59.6106 0.26338 




















Figure B3: Increasing receptor anisotropy upon photobleaching of CHO cells expressing 
























Table C1: CFP/YFPSE ratio of CHO cells expressing FLAG-LHR-YFP +ICUE3 and treated 































































































Figure C1: CFP/YFPSE ratio of CHO cells expressed Flag-LHR-YFP +ICUE3 and treated with  




















Table C2: CFP/YFPSE ratio of CHO cells expressing FLAG-LHR-YFP +ICUE3 and treated 















































































Figure C2: CFP/YFPSE ratio of CHO cells expressing FLAG-LHR-YFP +ICUE3 and treated 


























Table C3: CFP/YFPSE ratio of CHO cells expressing FLAG-LHR-YFP +ICUE3 and treated 
















































































Figure C3: CFP/YFPSE ratio of CHO cells expressing FLAG-LHR-YFP +ICUE3 and treated 






























LIST OF ABBREVIATIONS 
AC                 adenyl cyclase 
Asn asparagin 
ATP                   adenosine triphosphate  
ADP adenosine diphosphate 
BRET bioluminescence resonance energy transfer 
BSA bovine serum albumin 
cm centimeter 
CO2 carbon dioxide 
Cys cysteine 
Ca+2 calcium ion 
cAMP cyclic adenosine monophosphate 
CFP cyan fluorescent protein 
CHO Chinese hamster ovary 
DMEM Dulbecco’s modified minimum essential medium 
D diffusion coefficient 
DAG diacylglycerol 
ECFP enhanced cyan fluorescent protein  
%E percent energy transfer efficiency 
EDTA ethylenediaminetetraacetic acid 
EPAC exchange protein activated by cAMP 
FRAP fluorescence recovery after photobleaching 
FCS fluorescence correlation spectroscopy 
FBS fetal bovine serum 
FITC fluorescein isothiocyanate 
FSH follicle stimulating hormone 
g g-factor 
GFP green fluorescent protein 
GPCR G protein-coupled receptor 
Gs stimulatory G protein 
123 
GDP guanosine diphosphate 
GTP guanosine triphosphate 
hCG human chorionic gonadotropin 
hetero-FRET hetero-transfer fluorescence resonance energy transfer 
homo-FRET homo-transfer fluorescence resonance energy transfer 
I intensity 
IP3 inositol 1,4,5 triphosphate                                                                     
LRR leucine rich repeat domain 
LH luteinizing hormone 
LHR luteinizing hormone receptor 
LP lipofectamine 
MβCD methyl-beta-cyclodextrin 
µm micrometer  
MEM modified minimum essential medium 
mGlnR metabotropic glutamate receptor 
MSD mean square displacement  
PBS phosphate buffered saline 
PKA protein kinase A 
PKC protein kinase C 
PLC phospholipase C 
PIP2 phosphatidylinositol 4,5-bisphosphate 
QD quantum dots 
r anisotropy 
SPT single particle tracking 
sec seconds 
TM transmembrane 
TSH thyroid stimulating hormone 
TrITC tetramethylrhodamine isothiocyanate   
YFP yellow fluorescent protein 
YFPSE sensitized yellow fluorescent protein  
 
